BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 021173
(316 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4
pdb|2NRY|B Chain B, Crystal Structure Of Irak-4
pdb|2NRY|C Chain C, Crystal Structure Of Irak-4
pdb|2NRY|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 65.5 bits (158), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 51/134 (38%), Positives = 72/134 (53%), Gaps = 17/134 (12%)
Query: 176 NFFSDRCIS-------EGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKE-FINDV 227
N F +R IS EG V+Y+ + KK A V + +++ +K+ F ++
Sbjct: 25 NNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMV---DITTEELKQQFDQEI 81
Query: 228 NTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSL-DRLIYGRSDG-PPIDWNTRVK 285
+A QH NL +LLGF + DG D L+Y + +GSL DRL DG PP+ W+ R K
Sbjct: 82 KVMAKCQHENLVELLGF-SSDGDD-LCLVYVYMPNGSLLDRL--SCLDGTPPLSWHMRCK 137
Query: 286 IALCAAQGLTFLHE 299
IA AA G+ FLHE
Sbjct: 138 IAQGAANGINFLHE 151
>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4
pdb|2NRU|B Chain B, Crystal Structure Of Irak-4
pdb|2NRU|C Chain C, Crystal Structure Of Irak-4
pdb|2NRU|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 65.5 bits (158), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 51/134 (38%), Positives = 72/134 (53%), Gaps = 17/134 (12%)
Query: 176 NFFSDRCIS-------EGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKE-FINDV 227
N F +R IS EG V+Y+ + KK A V + +++ +K+ F ++
Sbjct: 25 NNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMV---DITTEELKQQFDQEI 81
Query: 228 NTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSL-DRLIYGRSDG-PPIDWNTRVK 285
+A QH NL +LLGF + DG D L+Y + +GSL DRL DG PP+ W+ R K
Sbjct: 82 KVMAKCQHENLVELLGF-SSDGDD-LCLVYVYMPNGSLLDRL--SCLDGTPPLSWHMRCK 137
Query: 286 IALCAAQGLTFLHE 299
IA AA G+ FLHE
Sbjct: 138 IAQGAANGINFLHE 151
>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|B Chain B, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|C Chain C, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|D Chain D, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIC|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OID|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
Length = 301
Score = 65.1 bits (157), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 51/134 (38%), Positives = 72/134 (53%), Gaps = 17/134 (12%)
Query: 176 NFFSDRCIS-------EGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKE-FINDV 227
N F +R IS EG V+Y+ + KK A V + +++ +K+ F ++
Sbjct: 19 NNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMV---DITTEELKQQFDQEI 75
Query: 228 NTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSL-DRLIYGRSDG-PPIDWNTRVK 285
+A QH NL +LLGF + DG D L+Y + +GSL DRL DG PP+ W+ R K
Sbjct: 76 KVMAKCQHENLVELLGF-SSDGDD-LCLVYVYMPNGSLLDRL--SCLDGTPPLSWHMRCK 131
Query: 286 IALCAAQGLTFLHE 299
IA AA G+ FLHE
Sbjct: 132 IAQGAANGINFLHE 145
>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|B Chain B, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|C Chain C, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|D Chain D, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
Length = 327
Score = 62.8 bits (151), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 47/135 (34%), Positives = 76/135 (56%), Gaps = 10/135 (7%)
Query: 166 PLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFIN 225
PL ++ A +NF I G+ +Y+ D A + K R SSQG++EF
Sbjct: 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALK-----RRTPESSQGIEEFET 84
Query: 226 DVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGP--PIDWNTR 283
++ TL+ +HP+L L+GF D ++ +LIY+ + +G+L R +YG SD P + W R
Sbjct: 85 EIETLSFCRHPHLVSLIGFC--DERNEMILIYKYMENGNLKRHLYG-SDLPTMSMSWEQR 141
Query: 284 VKIALCAAQGLTFLH 298
++I + AA+GL +LH
Sbjct: 142 LEICIGAARGLHYLH 156
>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By
Bacterial Effector Protein Avrpto
Length = 321
Score = 62.8 bits (151), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 47/135 (34%), Positives = 76/135 (56%), Gaps = 10/135 (7%)
Query: 166 PLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFIN 225
PL ++ A +NF I G+ +Y+ D A + K R SSQG++EF
Sbjct: 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALK-----RRTPESSQGIEEFET 84
Query: 226 DVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGP--PIDWNTR 283
++ TL+ +HP+L L+GF D ++ +LIY+ + +G+L R +YG SD P + W R
Sbjct: 85 EIETLSFCRHPHLVSLIGFC--DERNEMILIYKYMENGNLKRHLYG-SDLPTMSMSWEQR 141
Query: 284 VKIALCAAQGLTFLH 298
++I + AA+GL +LH
Sbjct: 142 LEICIGAARGLHYLH 156
>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain
pdb|2O8Y|B Chain B, Apo Irak4 Kinase Domain
Length = 298
Score = 62.4 bits (150), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 51/134 (38%), Positives = 70/134 (52%), Gaps = 17/134 (12%)
Query: 176 NFFSDRCIS-------EGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKE-FINDV 227
N F +R IS EG V+Y+ + KK A V + +++ +K+ F ++
Sbjct: 16 NNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMV---DITTEELKQQFDQEI 72
Query: 228 NTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSL-DRLIYGRSDG-PPIDWNTRVK 285
A QH NL +LLGF + DG D L+Y +GSL DRL DG PP+ W+ R K
Sbjct: 73 KVXAKCQHENLVELLGF-SSDGDD-LCLVYVYXPNGSLLDRL--SCLDGTPPLSWHXRCK 128
Query: 286 IALCAAQGLTFLHE 299
IA AA G+ FLHE
Sbjct: 129 IAQGAANGINFLHE 142
>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On
Plant Receptor- Like Kinase Bak1 Activation
pdb|3ULZ|A Chain A, Crystal Structure Of Apo Bak1
Length = 326
Score = 57.8 bits (138), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 40/140 (28%), Positives = 67/140 (47%), Gaps = 11/140 (7%)
Query: 163 RNFPLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNP--SSQGV 220
+ F L E+ A NF + + G +Y+ D + V RL + G
Sbjct: 18 KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVA------VKRLKEERTQGGE 71
Query: 221 KEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG-PPID 279
+F +V ++ H NL +L GF +R+L+Y + +GS+ + R + PP+D
Sbjct: 72 LQFQTEVEMISMAVHRNLLRLRGFCMT--PTERLLVYPYMANGSVASCLRERPESQPPLD 129
Query: 280 WNTRVKIALCAAQGLTFLHE 299
W R +IAL +A+GL +LH+
Sbjct: 130 WPKRQRIALGSARGLAYLHD 149
>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|D Chain D, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|G Chain G, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|H Chain H, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
Length = 349
Score = 57.0 bits (136), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 40/140 (28%), Positives = 66/140 (47%), Gaps = 11/140 (7%)
Query: 163 RNFPLDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ--GV 220
+ F L E+ A NF + + G +Y+ D + V RL G
Sbjct: 26 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVA------VKRLKEERXQGGE 79
Query: 221 KEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG-PPID 279
+F +V ++ H NL +L GF +R+L+Y + +GS+ + R + PP+D
Sbjct: 80 LQFQTEVEMISMAVHRNLLRLRGFCMT--PTERLLVYPYMANGSVASCLRERPESQPPLD 137
Query: 280 WNTRVKIALCAAQGLTFLHE 299
W R +IAL +A+GL +LH+
Sbjct: 138 WPKRQRIALGSARGLAYLHD 157
>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
pdb|3P86|B Chain B, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
Length = 309
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 32/121 (26%), Positives = 54/121 (44%), Gaps = 8/121 (6%)
Query: 183 ISEGLSSVMYRASF-GDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKL 241
I G ++RA + G D + E ++ V EF+ +V + L+HPN+
Sbjct: 45 IGAGSFGTVHRAEWHGSDVAVKILMEQDF-----HAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 242 LGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEG 301
+G A ++ E L GSL RL++ +D R+ +A A+G+ +LH
Sbjct: 100 MG--AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 302 P 302
P
Sbjct: 158 P 158
>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
pdb|3PPZ|B Chain B, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
Length = 309
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 32/121 (26%), Positives = 54/121 (44%), Gaps = 8/121 (6%)
Query: 183 ISEGLSSVMYRASF-GDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKL 241
I G ++RA + G D + E ++ V EF+ +V + L+HPN+
Sbjct: 45 IGAGSFGTVHRAEWHGSDVAVKILMEQDF-----HAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 242 LGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEG 301
+G A ++ E L GSL RL++ +D R+ +A A+G+ +LH
Sbjct: 100 MG--AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 302 P 302
P
Sbjct: 158 P 158
>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|2P0C|B Chain B, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|3BRB|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BRB|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BPR|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|C Chain C, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|D Chain D, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3TCP|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
pdb|3TCP|B Chain B, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
Length = 313
Score = 38.9 bits (89), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 34/138 (24%), Positives = 63/138 (45%), Gaps = 7/138 (5%)
Query: 167 LDEVAAACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ-GVKEFIN 225
L++V + + + EG + + + TS K +L+ SSQ ++EF++
Sbjct: 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLS 85
Query: 226 DVNTLASLQHPNLCKLLGF---HARDGSDQRMLIYERLFHGSLD-RLIYGRSDGPP--ID 279
+ + HPN+ +LLG + G + M+I + +G L L+Y R + P I
Sbjct: 86 EAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIP 145
Query: 280 WNTRVKIALCAAQGLTFL 297
T +K + A G+ +L
Sbjct: 146 LQTLLKFMVDIALGMEYL 163
>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound
To Appcp From D. Discoideum
Length = 287
Score = 38.9 bits (89), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 22/83 (26%), Positives = 40/83 (48%), Gaps = 8/83 (9%)
Query: 221 KEFINDVNTLASLQHPNLCKLLGF-HARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPID 279
+EF +V +++L HPN+ KL G H + L+H LD+ PI
Sbjct: 68 QEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDK-------AHPIK 120
Query: 280 WNTRVKIALCAAQGLTFLHEEGP 302
W+ ++++ L A G+ ++ + P
Sbjct: 121 WSVKLRLMLDIALGIEYMQNQNP 143
>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain
From D. Discoideum Bound To Appcp
Length = 287
Score = 38.9 bits (89), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 22/83 (26%), Positives = 40/83 (48%), Gaps = 8/83 (9%)
Query: 221 KEFINDVNTLASLQHPNLCKLLGF-HARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPID 279
+EF +V +++L HPN+ KL G H + L+H LD+ PI
Sbjct: 68 QEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDK-------AHPIK 120
Query: 280 WNTRVKIALCAAQGLTFLHEEGP 302
W+ ++++ L A G+ ++ + P
Sbjct: 121 WSVKLRLMLDIALGIEYMQNQNP 143
>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To
Appcp From D. Discoideum
pdb|4F0G|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum
pdb|4F1T|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum Bound To The Rock Inhibitor H1152
Length = 287
Score = 38.5 bits (88), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 22/83 (26%), Positives = 40/83 (48%), Gaps = 8/83 (9%)
Query: 221 KEFINDVNTLASLQHPNLCKLLGF-HARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPID 279
+EF +V +++L HPN+ KL G H + L+H LD+ PI
Sbjct: 68 QEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDK-------AHPIK 120
Query: 280 WNTRVKIALCAAQGLTFLHEEGP 302
W+ ++++ L A G+ ++ + P
Sbjct: 121 WSVKLRLMLDIALGIEYMQNQNP 143
>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
pdb|3S95|B Chain B, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
Length = 310
Score = 38.5 bits (88), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 26/90 (28%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 210 VTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRM-LIYERLFHGSLDRL 268
+ R + +Q + F+ +V + L+HPN+ K +G + D+R+ I E + G+L +
Sbjct: 43 LIRFDEETQ--RTFLKEVKVMRCLEHPNVLKFIGVLYK---DKRLNFITEYIKGGTLRGI 97
Query: 269 IYGRSDGPPIDWNTRVKIALCAAQGLTFLH 298
I P W+ RV A A G+ +LH
Sbjct: 98 IKSMDSQYP--WSQRVSFAKDIASGMAYLH 125
>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp
Length = 298
Score = 38.1 bits (87), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 31/123 (25%), Positives = 51/123 (41%), Gaps = 5/123 (4%)
Query: 179 SDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNL 238
SDR I +G V+Y + D A + Q V+ F+ + + L HPN+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 239 CKLLGFHA-RDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFL 297
L+G +G +L Y + HG L + I P + + L A+G+ +L
Sbjct: 85 LALIGIMLPPEGLPHVLLPY--MCHGDLLQFIRSPQRNPTV--KDLISFGLQVARGMEYL 140
Query: 298 HEE 300
E+
Sbjct: 141 AEQ 143
>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed
With Compound 16
Length = 271
Score = 38.1 bits (87), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 33/119 (27%), Positives = 54/119 (45%), Gaps = 14/119 (11%)
Query: 191 MYRASFGDDASTSKKFEATVTRLNPS---SQGVKEFINDVNTLASLQHPNLCKLLGFHAR 247
+YRA + D K R +P SQ ++ + A L+HPN+ L G +
Sbjct: 23 VYRAFWIGDEVAVKA-----ARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK 77
Query: 248 DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQVI 306
+ L+ E G L+R++ G+ P I N V+I A+G+ +LH+E +I
Sbjct: 78 E--PNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQI----ARGMNYLHDEAIVPII 130
>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972
pdb|3QTI|B Chain B, C-Met Kinase In Complex With Nvp-Bvu972
Length = 314
Score = 37.0 bits (84), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 32/121 (26%), Positives = 50/121 (41%), Gaps = 9/121 (7%)
Query: 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ--GVKEFINDVNTLASLQHPN 237
+ I G +Y + D+ KK V LN + V +F+ + + HPN
Sbjct: 35 NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 238 LCKLLGFHAR-DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTF 296
+ LLG R +GS +L Y + HG L I + P + + L A+G+ F
Sbjct: 93 VLSLLGICLRSEGSPLVVLPYMK--HGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKF 148
Query: 297 L 297
L
Sbjct: 149 L 149
>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolotriazine Based Inhibitor
Length = 373
Score = 37.0 bits (84), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 32/121 (26%), Positives = 50/121 (41%), Gaps = 9/121 (7%)
Query: 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ--GVKEFINDVNTLASLQHPN 237
+ I G +Y + D+ KK V LN + V +F+ + + HPN
Sbjct: 94 NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 238 LCKLLGFHAR-DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTF 296
+ LLG R +GS +L Y + HG L I + P + + L A+G+ F
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMK--HGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKF 207
Query: 297 L 297
L
Sbjct: 208 L 208
>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With
6-Benzyloxyquinoline Inhibitor
Length = 319
Score = 37.0 bits (84), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 32/121 (26%), Positives = 50/121 (41%), Gaps = 9/121 (7%)
Query: 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ--GVKEFINDVNTLASLQHPN 237
+ I G +Y + D+ KK V LN + V +F+ + + HPN
Sbjct: 40 NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 97
Query: 238 LCKLLGFHAR-DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTF 296
+ LLG R +GS +L Y + HG L I + P + + L A+G+ F
Sbjct: 98 VLSLLGICLRSEGSPLVVLPYMK--HGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKF 153
Query: 297 L 297
L
Sbjct: 154 L 154
>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
The Microbial Alkaloid K-252a
pdb|1R1W|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met
Length = 312
Score = 36.6 bits (83), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 32/121 (26%), Positives = 50/121 (41%), Gaps = 9/121 (7%)
Query: 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ--GVKEFINDVNTLASLQHPN 237
+ I G +Y + D+ KK V LN + V +F+ + + HPN
Sbjct: 33 NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 238 LCKLLGFHAR-DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTF 296
+ LLG R +GS +L Y + HG L I + P + + L A+G+ F
Sbjct: 91 VLSLLGICLRSEGSPLVVLPYMK--HGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKF 146
Query: 297 L 297
L
Sbjct: 147 L 147
>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1
pdb|3DKF|A Chain A, Sgx Clone 5698a65kfg1h1
Length = 317
Score = 36.6 bits (83), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 32/121 (26%), Positives = 50/121 (41%), Gaps = 9/121 (7%)
Query: 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ--GVKEFINDVNTLASLQHPN 237
+ I G +Y + D+ KK V LN + V +F+ + + HPN
Sbjct: 36 NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 238 LCKLLGFHAR-DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTF 296
+ LLG R +GS +L Y + HG L I + P + + L A+G+ F
Sbjct: 94 VLSLLGICLRSEGSPLVVLPYMK--HGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKF 149
Query: 297 L 297
L
Sbjct: 150 L 150
>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CTJ|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CE3|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolopyridinepyridone Based Inhibitor
pdb|3F82|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
N-
(4-(2-Amino-3-Chloropyridin-4-Yloxy)-3-Fluorophenyl)-4-
Ethoxy-1-(4-Fluorophenyl)-2-Oxo-1,2-Dihydropyridine-3-
Carboxamide
pdb|3L8V|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepat Growth Factor Receptor C-Met In Complex With A
Biarylamine Inhibitor
Length = 314
Score = 36.6 bits (83), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 32/121 (26%), Positives = 50/121 (41%), Gaps = 9/121 (7%)
Query: 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ--GVKEFINDVNTLASLQHPN 237
+ I G +Y + D+ KK V LN + V +F+ + + HPN
Sbjct: 35 NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 238 LCKLLGFHAR-DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTF 296
+ LLG R +GS +L Y + HG L I + P + + L A+G+ F
Sbjct: 93 VLSLLGICLRSEGSPLVVLPYMK--HGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKF 148
Query: 297 L 297
L
Sbjct: 149 L 149
>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1
Length = 317
Score = 36.6 bits (83), Expect = 0.018, Method: Compositional matrix adjust.
Identities = 32/121 (26%), Positives = 50/121 (41%), Gaps = 9/121 (7%)
Query: 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ--GVKEFINDVNTLASLQHPN 237
+ I G +Y + D+ KK V LN + V +F+ + + HPN
Sbjct: 36 NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 238 LCKLLGFHAR-DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTF 296
+ LLG R +GS +L Y + HG L I + P + + L A+G+ F
Sbjct: 94 VLSLLGICLRSEGSPLVVLPYMK--HGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKF 149
Query: 297 L 297
L
Sbjct: 150 L 150
>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain
pdb|4AT3|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Cpd5n
pdb|4AT4|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Ex429
pdb|4AT5|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Gw2580
Length = 299
Score = 36.6 bits (83), Expect = 0.020, Method: Compositional matrix adjust.
Identities = 26/103 (25%), Positives = 45/103 (43%), Gaps = 5/103 (4%)
Query: 175 HNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLASL 233
HN R + EG ++ A + K V L +S K+F + L +L
Sbjct: 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 72
Query: 234 QHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGP 276
QH ++ K G D ++++E + HG L++ + R+ GP
Sbjct: 73 QHEHIVKFYGVCVE--GDPLIMVFEYMKHGDLNKFL--RAHGP 111
>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With
Its Activating Protein Tab1
pdb|2YIY|A Chain A, Crystal Structure Of Compound 8 Bound To Tak1-Tab
Length = 307
Score = 36.2 bits (82), Expect = 0.022, Method: Compositional matrix adjust.
Identities = 29/120 (24%), Positives = 50/120 (41%), Gaps = 4/120 (3%)
Query: 187 LSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHA 246
+ V+ R +FG + + + S K FI ++ L+ + HPN+ KL G
Sbjct: 12 VEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYG--- 68
Query: 247 RDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQVI 306
+ L+ E GSL +++G P + L +QG+ +LH P +I
Sbjct: 69 -ACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol
Length = 315
Score = 36.2 bits (82), Expect = 0.022, Method: Compositional matrix adjust.
Identities = 29/120 (24%), Positives = 50/120 (41%), Gaps = 4/120 (3%)
Query: 187 LSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHA 246
+ V+ R +FG + + + S K FI ++ L+ + HPN+ KL G
Sbjct: 13 VEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYG--- 69
Query: 247 RDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHEEGPFQVI 306
+ L+ E GSL +++G P + L +QG+ +LH P +I
Sbjct: 70 -ACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 128
>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
pdb|3V5Q|B Chain B, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
Length = 297
Score = 36.2 bits (82), Expect = 0.027, Method: Compositional matrix adjust.
Identities = 27/97 (27%), Positives = 48/97 (49%), Gaps = 5/97 (5%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRL-NPSSQGVKEFINDVNTLASLQHPNLC 239
R + EG ++ A + + T K V L +P+ K+F + L +LQH ++
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 240 KLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGP 276
K G DG D ++++E + HG L++ + R+ GP
Sbjct: 81 KFYGV-CGDG-DPLIMVFEYMKHGDLNKFL--RAHGP 113
>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|E Chain E, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|D Chain D, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4N|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E4N|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E5W|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4E5W|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4EHZ|A Chain A, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|B Chain B, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|C Chain C, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|D Chain D, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EI4|A Chain A, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4EI4|B Chain B, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4FK6|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
pdb|4FK6|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
Length = 302
Score = 36.2 bits (82), Expect = 0.027, Method: Compositional matrix adjust.
Identities = 26/93 (27%), Positives = 42/93 (45%), Gaps = 4/93 (4%)
Query: 207 EATVTRLNPSSQG--VKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGS 264
+ V L P S G + + ++ L +L H N+ K G DG + LI E L GS
Sbjct: 52 QVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGS 111
Query: 265 LDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFL 297
L Y + I+ ++K A+ +G+ +L
Sbjct: 112 LKE--YLPKNKNKINLKQQLKYAVQICKGMDYL 142
>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3EYH|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 290
Score = 35.8 bits (81), Expect = 0.032, Method: Compositional matrix adjust.
Identities = 26/93 (27%), Positives = 42/93 (45%), Gaps = 4/93 (4%)
Query: 207 EATVTRLNPSSQG--VKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGS 264
+ V L P S G + + ++ L +L H N+ K G DG + LI E L GS
Sbjct: 40 QVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGS 99
Query: 265 LDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFL 297
L Y + I+ ++K A+ +G+ +L
Sbjct: 100 LKE--YLPKNKNKINLKQQLKYAVQICKGMDYL 130
>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain
Of C-Met
pdb|2WKM|A Chain A, X-Ray Structure Of Pha-00665752 Bound To The Kinase Domain
Of C-Met
pdb|3ZXZ|A Chain A, X-Ray Structure Of Pf-04217903 Bound To The Kinase Domain
Of C-Met
pdb|3ZZE|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
N'-
((3z)-4-Chloro-7-Methyl-2-Oxo-1,2-Dihydro-3h-Indol-3-
Ylidene)-2-(4-Hydroxyphenyl)propanohydrazide
pdb|4AOI|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( 3-((1h-
Pyrrolo(2,3-B)pyridin-3-Yl)methyl)-(1,2,4)triazolo(
4,3-B)(1,2,4) Triazin-6-Yl)benzonitrile
pdb|4AP7|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( (6-(4-
Fluorophenyl)-(1,2,4)triazolo(4,3-B)(1,2,
4)triazin-3-Yl)methyl) Phenol
Length = 306
Score = 35.8 bits (81), Expect = 0.034, Method: Compositional matrix adjust.
Identities = 31/121 (25%), Positives = 50/121 (41%), Gaps = 9/121 (7%)
Query: 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ--GVKEFINDVNTLASLQHPN 237
+ I G +Y + D+ KK V LN + V +F+ + + HPN
Sbjct: 32 NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 238 LCKLLGFHAR-DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTF 296
+ LLG R +GS +L Y + HG L I + P + + L A+G+ +
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMK--HGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 145
Query: 297 L 297
L
Sbjct: 146 L 146
>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880
(Gsk1
Length = 302
Score = 35.8 bits (81), Expect = 0.034, Method: Compositional matrix adjust.
Identities = 31/121 (25%), Positives = 50/121 (41%), Gaps = 9/121 (7%)
Query: 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ--GVKEFINDVNTLASLQHPN 237
+ I G +Y + D+ KK V LN + V +F+ + + HPN
Sbjct: 33 NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 238 LCKLLGFHAR-DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTF 296
+ LLG R +GS +L Y + HG L I + P + + L A+G+ +
Sbjct: 91 VLSLLGICLRSEGSPLVVLPYMK--HGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 146
Query: 297 L 297
L
Sbjct: 147 L 147
>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The
Dually-Phosphorylated, Activated State
Length = 308
Score = 35.8 bits (81), Expect = 0.034, Method: Compositional matrix adjust.
Identities = 31/121 (25%), Positives = 50/121 (41%), Gaps = 9/121 (7%)
Query: 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ--GVKEFINDVNTLASLQHPN 237
+ I G +Y + D+ KK V LN + V +F+ + + HPN
Sbjct: 35 NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 238 LCKLLGFHAR-DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTF 296
+ LLG R +GS +L Y + HG L I + P + + L A+G+ +
Sbjct: 93 VLSLLGICLRSEGSPLVVLPYMK--HGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 148
Query: 297 L 297
L
Sbjct: 149 L 149
>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
pdb|4GG7|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
Length = 319
Score = 35.8 bits (81), Expect = 0.035, Method: Compositional matrix adjust.
Identities = 31/121 (25%), Positives = 50/121 (41%), Gaps = 9/121 (7%)
Query: 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ--GVKEFINDVNTLASLQHPN 237
+ I G +Y + D+ KK V LN + V +F+ + + HPN
Sbjct: 54 NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 111
Query: 238 LCKLLGFHAR-DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTF 296
+ LLG R +GS +L Y + HG L I + P + + L A+G+ +
Sbjct: 112 VLSLLGICLRSEGSPLVVLPYMK--HGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 167
Query: 297 L 297
L
Sbjct: 168 L 168
>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor
Length = 292
Score = 35.8 bits (81), Expect = 0.035, Method: Compositional matrix adjust.
Identities = 31/121 (25%), Positives = 50/121 (41%), Gaps = 9/121 (7%)
Query: 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ--GVKEFINDVNTLASLQHPN 237
+ I G +Y + D+ KK V LN + V +F+ + + HPN
Sbjct: 27 NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 84
Query: 238 LCKLLGFHAR-DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTF 296
+ LLG R +GS +L Y + HG L I + P + + L A+G+ +
Sbjct: 85 VLSLLGICLRSEGSPLVVLPYMK--HGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 140
Query: 297 L 297
L
Sbjct: 141 L 141
>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In
Complex With An Mk-2461 Analog With Specificity For The
Activated Receptor
pdb|3R7O|A Chain A, Structure Of Dually Phosphorylated C-Met Receptor Kinase
In Complex With An Mk-2461 Analog
Length = 307
Score = 35.8 bits (81), Expect = 0.036, Method: Compositional matrix adjust.
Identities = 31/121 (25%), Positives = 50/121 (41%), Gaps = 9/121 (7%)
Query: 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ--GVKEFINDVNTLASLQHPN 237
+ I G +Y + D+ KK V LN + V +F+ + + HPN
Sbjct: 34 NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 238 LCKLLGFHAR-DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTF 296
+ LLG R +GS +L Y + HG L I + P + + L A+G+ +
Sbjct: 92 VLSLLGICLRSEGSPLVVLPYMK--HGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 147
Query: 297 L 297
L
Sbjct: 148 L 148
>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor.
pdb|2RFN|B Chain B, X-ray Structure Of C-met With Inhibitor.
pdb|2RFS|A Chain A, X-Ray Structure Of Su11274 Bound To C-Met
pdb|3CCN|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3CD8|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3EFJ|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFJ|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFK|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 50
pdb|3EFK|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 50
Length = 310
Score = 35.8 bits (81), Expect = 0.036, Method: Compositional matrix adjust.
Identities = 31/121 (25%), Positives = 50/121 (41%), Gaps = 9/121 (7%)
Query: 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ--GVKEFINDVNTLASLQHPN 237
+ I G +Y + D+ KK V LN + V +F+ + + HPN
Sbjct: 35 NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 238 LCKLLGFHAR-DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTF 296
+ LLG R +GS +L Y + HG L I + P + + L A+G+ +
Sbjct: 93 VLSLLGICLRSEGSPLVVLPYMK--HGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 148
Query: 297 L 297
L
Sbjct: 149 L 149
>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
pdb|3F66|B Chain B, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
Length = 298
Score = 35.8 bits (81), Expect = 0.036, Method: Compositional matrix adjust.
Identities = 31/121 (25%), Positives = 50/121 (41%), Gaps = 9/121 (7%)
Query: 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ--GVKEFINDVNTLASLQHPN 237
+ I G +Y + D+ KK V LN + V +F+ + + HPN
Sbjct: 30 NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 238 LCKLLGFHAR-DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTF 296
+ LLG R +GS +L Y + HG L I + P + + L A+G+ +
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMK--HGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 143
Query: 297 L 297
L
Sbjct: 144 L 144
>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine
Inhibitor 13
pdb|3U6H|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 26
pdb|3U6I|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 58a
pdb|4DEG|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridazine Inhibitor 2
pdb|4DEH|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 3
pdb|4DEI|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 24
Length = 309
Score = 35.8 bits (81), Expect = 0.036, Method: Compositional matrix adjust.
Identities = 31/121 (25%), Positives = 50/121 (41%), Gaps = 9/121 (7%)
Query: 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ--GVKEFINDVNTLASLQHPN 237
+ I G +Y + D+ KK V LN + V +F+ + + HPN
Sbjct: 34 NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 238 LCKLLGFHAR-DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTF 296
+ LLG R +GS +L Y + HG L I + P + + L A+G+ +
Sbjct: 92 VLSLLGICLRSEGSPLVVLPYMK--HGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 147
Query: 297 L 297
L
Sbjct: 148 L 148
>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg-
1009247
Length = 270
Score = 35.4 bits (80), Expect = 0.038, Method: Compositional matrix adjust.
Identities = 24/75 (32%), Positives = 38/75 (50%), Gaps = 5/75 (6%)
Query: 200 ASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYER 259
A+ +K + V + P S V+ F+ + N + +LQH L KL HA + +I E
Sbjct: 34 ATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL---HAVVTKEPIYIITEF 90
Query: 260 LFHGSLDRLIYGRSD 274
+ GSL L + +SD
Sbjct: 91 MAKGSL--LDFLKSD 103
>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase
pdb|3RHK|A Chain A, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
pdb|3RHK|B Chain B, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
Length = 318
Score = 35.4 bits (80), Expect = 0.041, Method: Compositional matrix adjust.
Identities = 31/121 (25%), Positives = 50/121 (41%), Gaps = 9/121 (7%)
Query: 180 DRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQ--GVKEFINDVNTLASLQHPN 237
+ I G +Y + D+ KK V LN + V +F+ + + HPN
Sbjct: 53 NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 110
Query: 238 LCKLLGFHAR-DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTF 296
+ LLG R +GS +L Y + HG L I + P + + L A+G+ +
Sbjct: 111 VLSLLGICLRSEGSPLVVLPYMK--HGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 166
Query: 297 L 297
L
Sbjct: 167 L 167
>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
pdb|3G2F|B Chain B, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
Length = 336
Score = 35.4 bits (80), Expect = 0.046, Method: Compositional matrix adjust.
Identities = 31/125 (24%), Positives = 53/125 (42%), Gaps = 18/125 (14%)
Query: 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKEFINDVNT--LASLQHPNLCK 240
I G +Y+ S + K F S + FIN+ N + ++H N+ +
Sbjct: 21 IGRGRYGAVYKGSLDERPVAVKVF---------SFANRQNFINEKNIYRVPLMEHDNIAR 71
Query: 241 LLGFHARDGSDQRM---LIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFL 297
+ R +D RM L+ E +GSL + + + DW + ++A +GL +L
Sbjct: 72 FIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS----DWVSSCRLAHSVTRGLAYL 127
Query: 298 HEEGP 302
H E P
Sbjct: 128 HTELP 132
>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dorsomorphin
pdb|3Q4T|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dorsomorphin
pdb|3SOC|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With A Quinazolin
pdb|3SOC|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With A Quinazolin
pdb|4ASX|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dihydro-Bauerine C
pdb|4ASX|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dihydro-Bauerine C
Length = 322
Score = 35.4 bits (80), Expect = 0.047, Method: Compositional matrix adjust.
Identities = 24/79 (30%), Positives = 36/79 (45%), Gaps = 6/79 (7%)
Query: 226 DVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFH--GSLDRLIYGRSDGPPIDWNTR 283
+V +L ++H N+ + +G R S L FH GSL + + WN
Sbjct: 68 EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNEL 123
Query: 284 VKIALCAAQGLTFLHEEGP 302
IA A+GL +LHE+ P
Sbjct: 124 CHIAETMARGLAYLHEDIP 142
>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex
pdb|1AD5|B Chain B, Src Family Kinase Hck-Amp-Pnp Complex
pdb|2HCK|A Chain A, Src Family Kinase Hck-Quercetin Complex
pdb|2HCK|B Chain B, Src Family Kinase Hck-Quercetin Complex
Length = 438
Score = 35.0 bits (79), Expect = 0.054, Method: Compositional matrix adjust.
Identities = 21/66 (31%), Positives = 33/66 (50%), Gaps = 3/66 (4%)
Query: 200 ASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYER 259
A+ +K + V + P S V+ F+ + N + +LQH L KL HA + +I E
Sbjct: 201 ATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL---HAVVTKEPIYIITEF 257
Query: 260 LFHGSL 265
+ GSL
Sbjct: 258 MAKGSL 263
>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family-
Selective Tyrosine Kinase Inhibitor
pdb|2C0I|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0I|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0O|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0O|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0T|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-641359
pdb|2C0T|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-641359
Length = 454
Score = 35.0 bits (79), Expect = 0.055, Method: Compositional matrix adjust.
Identities = 21/66 (31%), Positives = 33/66 (50%), Gaps = 3/66 (4%)
Query: 200 ASTSKKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYER 259
A+ +K + V + P S V+ F+ + N + +LQH L KL HA + +I E
Sbjct: 207 ATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL---HAVVTKEPIYIITEF 263
Query: 260 LFHGSL 265
+ GSL
Sbjct: 264 MAKGSL 269
>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|C Chain C, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 299
Score = 34.3 bits (77), Expect = 0.083, Method: Compositional matrix adjust.
Identities = 34/124 (27%), Positives = 51/124 (41%), Gaps = 8/124 (6%)
Query: 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLASLQ 234
NF I EG V+Y+A + T + RL+ ++GV I +++ L L
Sbjct: 4 NFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 235 HPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGL 294
HPN+ KLL ++ L++E L D + G P+ L QGL
Sbjct: 61 HPNIVKLLD--VIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLL--QGL 116
Query: 295 TFLH 298
F H
Sbjct: 117 AFCH 120
>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
pdb|2R4B|B Chain B, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
Length = 321
Score = 34.3 bits (77), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 30/123 (24%), Positives = 57/123 (46%), Gaps = 12/123 (9%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSS--QGVKEFINDVNTLASLQHPNL 238
+ + G +Y+ + + T K + LN ++ + EF+++ +AS+ HP+L
Sbjct: 44 KVLGSGAFGTVYKGIWVPEGETVK-IPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 102
Query: 239 CKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSD--GPPIDWNTRVKIALCAAQGLTF 296
+LLG S L+ + + HG L ++ D G + N V+I A+G+ +
Sbjct: 103 VRLLGVCL---SPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI----AKGMMY 155
Query: 297 LHE 299
L E
Sbjct: 156 LEE 158
>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-dependent Kinase Inhibitors Identified Through
Structure-based Hybridisation
Length = 299
Score = 33.9 bits (76), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 35/125 (28%), Positives = 55/125 (44%), Gaps = 10/125 (8%)
Query: 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLASLQ 234
NF I EG V+Y+A + T + RL+ ++GV I +++ L L
Sbjct: 4 NFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 235 HPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCAAQG 293
HPN+ KLL ++ L++E L H L + + + G P+ L QG
Sbjct: 61 HPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL--QG 115
Query: 294 LTFLH 298
L+F H
Sbjct: 116 LSFCH 120
>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK6|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 33.9 bits (76), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 33 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 79
>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK3|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 33.9 bits (76), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 33 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 79
>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|C Chain C, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
Length = 302
Score = 33.9 bits (76), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 35/129 (27%), Positives = 55/129 (42%), Gaps = 10/129 (7%)
Query: 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTL 230
+ NF I EG V+Y+A + T + RL+ ++GV I +++ L
Sbjct: 3 GSMENFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLL 59
Query: 231 ASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALC 289
L HPN+ KLL ++ L++E L H L + + + G P+ L
Sbjct: 60 KELNHPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL 116
Query: 290 AAQGLTFLH 298
QGL F H
Sbjct: 117 --QGLAFCH 123
>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK7|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 277
Score = 33.9 bits (76), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 33 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 79
>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound
With Ppy-A
pdb|3IK3|A Chain A, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
pdb|3IK3|B Chain B, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
Length = 288
Score = 33.9 bits (76), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 35 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81
>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1FPU|B Chain B, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1IEP|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1IEP|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1M52|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1M52|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1OPJ|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPJ|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|2HZN|A Chain A, Abl Kinase Domain In Complex With Nvp-Afg210
pdb|3K5V|A Chain A, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3K5V|B Chain B, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3MS9|A Chain A, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MS9|B Chain B, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MSS|A Chain A, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|B Chain B, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|C Chain C, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|D Chain D, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
Length = 293
Score = 33.9 bits (76), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 40 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 86
>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|2QOH|B Chain B, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|3KF4|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KF4|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
Length = 288
Score = 33.9 bits (76), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 35 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81
>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant
Abl Mutant In Complex With The Aurora Kinase Inhibitor
Vx-680
Length = 287
Score = 33.9 bits (76), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 36 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 82
>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine
Length = 306
Score = 33.9 bits (76), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 35/125 (28%), Positives = 54/125 (43%), Gaps = 10/125 (8%)
Query: 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLASLQ 234
NF I EG V+Y+A + T + RL+ ++GV I +++ L L
Sbjct: 11 NFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 67
Query: 235 HPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCAAQG 293
HPN+ KLL ++ L++E L H L + + + G P+ L QG
Sbjct: 68 HPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL--QG 122
Query: 294 LTFLH 298
L F H
Sbjct: 123 LAFCH 127
>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
pdb|3OY3|B Chain B, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
Length = 284
Score = 33.9 bits (76), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 35 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81
>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
Length = 301
Score = 33.9 bits (76), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 35/129 (27%), Positives = 55/129 (42%), Gaps = 10/129 (7%)
Query: 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTL 230
+ NF I EG V+Y+A + T + RL+ ++GV I +++ L
Sbjct: 3 GSMENFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLL 59
Query: 231 ASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALC 289
L HPN+ KLL ++ L++E L H L + + + G P+ L
Sbjct: 60 KELNHPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL 116
Query: 290 AAQGLTFLH 298
QGL F H
Sbjct: 117 --QGLAFCH 123
>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCQ|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 301
Score = 33.9 bits (76), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 35/129 (27%), Positives = 55/129 (42%), Gaps = 10/129 (7%)
Query: 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTL 230
+ NF I EG V+Y+A + T + RL+ ++GV I +++ L
Sbjct: 2 GSMENFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLL 58
Query: 231 ASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALC 289
L HPN+ KLL ++ L++E L H L + + + G P+ L
Sbjct: 59 KELNHPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL 115
Query: 290 AAQGLTFLH 298
QGL F H
Sbjct: 116 --QGLAFCH 122
>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A
Dfg-Out Inhibitor Ap24534
Length = 284
Score = 33.9 bits (76), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 35 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81
>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|A Chain A, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|C Chain C, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|A Chain A, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|C Chain C, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|4BCO|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 300
Score = 33.9 bits (76), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 35/129 (27%), Positives = 55/129 (42%), Gaps = 10/129 (7%)
Query: 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTL 230
+ NF I EG V+Y+A + T + RL+ ++GV I +++ L
Sbjct: 1 GSMENFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLL 57
Query: 231 ASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALC 289
L HPN+ KLL ++ L++E L H L + + + G P+ L
Sbjct: 58 KELNHPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL 114
Query: 290 AAQGLTFLH 298
QGL F H
Sbjct: 115 --QGLAFCH 121
>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
pdb|2E2B|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
Length = 293
Score = 33.9 bits (76), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 40 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 86
>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 300
Score = 33.9 bits (76), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 35/129 (27%), Positives = 55/129 (42%), Gaps = 10/129 (7%)
Query: 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTL 230
+ NF I EG V+Y+A + T + RL+ ++GV I +++ L
Sbjct: 2 GSMENFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLL 58
Query: 231 ASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALC 289
L HPN+ KLL ++ L++E L H L + + + G P+ L
Sbjct: 59 KELNHPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL 115
Query: 290 AAQGLTFLH 298
QGL F H
Sbjct: 116 --QGLAFCH 122
>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site
pdb|3EZV|A Chain A, Cdk-2 With Indazole Inhibitor 9 Bound At Its Active Site
Length = 300
Score = 33.9 bits (76), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 35/129 (27%), Positives = 55/129 (42%), Gaps = 10/129 (7%)
Query: 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTL 230
+ NF I EG V+Y+A + T + RL+ ++GV I +++ L
Sbjct: 1 GSMENFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLL 57
Query: 231 ASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALC 289
L HPN+ KLL ++ L++E L H L + + + G P+ L
Sbjct: 58 KELNHPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL 114
Query: 290 AAQGLTFLH 298
QGL F H
Sbjct: 115 --QGLAFCH 121
>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine
pdb|2R3Q|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3M|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3I|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3N|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3O|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3P|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3K|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3J|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3L|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|1W8C|A Chain A, Co-crystal Structure Of
6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine And
Monomeric Cdk2
Length = 299
Score = 33.9 bits (76), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 35/125 (28%), Positives = 54/125 (43%), Gaps = 10/125 (8%)
Query: 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLASLQ 234
NF I EG V+Y+A + T + RL+ ++GV I +++ L L
Sbjct: 4 NFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 235 HPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCAAQG 293
HPN+ KLL ++ L++E L H L + + + G P+ L QG
Sbjct: 61 HPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL--QG 115
Query: 294 LTFLH 298
L F H
Sbjct: 116 LAFCH 120
>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
pdb|3PYY|B Chain B, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
Length = 298
Score = 33.9 bits (76), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 48 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 94
>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
Length = 299
Score = 33.9 bits (76), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 35/125 (28%), Positives = 54/125 (43%), Gaps = 10/125 (8%)
Query: 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLASLQ 234
NF I EG V+Y+A + T + RL+ ++GV I +++ L L
Sbjct: 4 NFQKVEKIGEGTYGVVYKAR---NKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELN 60
Query: 235 HPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCAAQG 293
HPN+ KLL ++ L++E L H L + + + G P+ L QG
Sbjct: 61 HPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL--QG 115
Query: 294 LTFLH 298
L F H
Sbjct: 116 LAFCH 120
>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
Length = 298
Score = 33.9 bits (76), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 35/125 (28%), Positives = 54/125 (43%), Gaps = 10/125 (8%)
Query: 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLASLQ 234
NF I EG V+Y+A + T + RL+ ++GV I +++ L L
Sbjct: 3 NFQKVEKIGEGTYGVVYKAR---NKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELN 59
Query: 235 HPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCAAQG 293
HPN+ KLL ++ L++E L H L + + + G P+ L QG
Sbjct: 60 HPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL--QG 114
Query: 294 LTFLH 298
L F H
Sbjct: 115 LAFCH 119
>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
pdb|2V7A|B Chain B, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
Length = 286
Score = 33.9 bits (76), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 36 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 82
>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
pdb|2HIW|B Chain B, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
Length = 287
Score = 33.9 bits (76), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 37 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 83
>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 300
Score = 33.9 bits (76), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 35/129 (27%), Positives = 55/129 (42%), Gaps = 10/129 (7%)
Query: 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTL 230
+ NF I EG V+Y+A + T + RL+ ++GV I +++ L
Sbjct: 2 GSMENFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLL 58
Query: 231 ASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALC 289
L HPN+ KLL ++ L++E L H L + + + G P+ L
Sbjct: 59 KELNHPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL 115
Query: 290 AAQGLTFLH 298
QGL F H
Sbjct: 116 --QGLAFCH 122
>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
pdb|3QRJ|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
Length = 277
Score = 33.9 bits (76), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 40 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 86
>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2F|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
Length = 287
Score = 33.9 bits (76), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 37 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 83
>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H24|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|A Chain A, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|C Chain C, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2WMA|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 303
Score = 33.9 bits (76), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 35/129 (27%), Positives = 55/129 (42%), Gaps = 10/129 (7%)
Query: 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTL 230
+ NF I EG V+Y+A + T + RL+ ++GV I +++ L
Sbjct: 4 GSMENFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLL 60
Query: 231 ASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALC 289
L HPN+ KLL ++ L++E L H L + + + G P+ L
Sbjct: 61 KELNHPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL 117
Query: 290 AAQGLTFLH 298
QGL F H
Sbjct: 118 --QGLAFCH 124
>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
Length = 299
Score = 33.9 bits (76), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 35/129 (27%), Positives = 55/129 (42%), Gaps = 10/129 (7%)
Query: 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTL 230
+ NF I EG V+Y+A + T + RL+ ++GV I +++ L
Sbjct: 1 GSMENFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLL 57
Query: 231 ASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALC 289
L HPN+ KLL ++ L++E L H L + + + G P+ L
Sbjct: 58 KELNHPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL 114
Query: 290 AAQGLTFLH 298
QGL F H
Sbjct: 115 --QGLAFCH 121
>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRI|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRK|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dp- 987
Length = 277
Score = 33.9 bits (76), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 40 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 86
>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|B Chain B, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|C Chain C, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|D Chain D, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HZ4|A Chain A, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|B Chain B, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|C Chain C, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
Length = 273
Score = 33.9 bits (76), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 35 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81
>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970
pdb|2HZI|B Chain B, Abl Kinase Domain In Complex With Pd180970
pdb|3CS9|A Chain A, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|B Chain B, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|C Chain C, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|D Chain D, Human Abl Kinase In Complex With Nilotinib
Length = 277
Score = 33.9 bits (76), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 39 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 85
>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
pdb|2GQG|B Chain B, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
Length = 278
Score = 33.9 bits (76), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 40 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 86
>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|C Chain C, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|D Chain D, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|3UE4|A Chain A, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
pdb|3UE4|B Chain B, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
Length = 287
Score = 33.9 bits (76), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 37 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 83
>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|C Chain C, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1PKD|A Chain A, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|C Chain C, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
Length = 297
Score = 33.5 bits (75), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 35/125 (28%), Positives = 54/125 (43%), Gaps = 10/125 (8%)
Query: 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLASLQ 234
NF I EG V+Y+A + T + RL+ ++GV I +++ L L
Sbjct: 4 NFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 235 HPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCAAQG 293
HPN+ KLL ++ L++E L H L + + + G P+ L QG
Sbjct: 61 HPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL--QG 115
Query: 294 LTFLH 298
L F H
Sbjct: 116 LAFCH 120
>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXQ|A Chain A, Cdk2 In Complex With 3 Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXR|A Chain A, Apo Cdk2 Crystallized From Jeffamine
pdb|3PXY|A Chain A, Cdk2 In Complex With Inhibitor Jws648
pdb|3PXZ|A Chain A, Cdk2 Ternary Complex With Jws648 And Ans
pdb|3PY0|A Chain A, Cdk2 In Complex With Inhibitor Su9516
pdb|3PY1|A Chain A, Cdk2 Ternary Complex With Su9516 And Ans
pdb|3QL8|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-260
pdb|3QQF|A Chain A, Cdk2 In Complex With Inhibitor L1
pdb|3QQG|A Chain A, Cdk2 In Complex With Inhibitor L2-5
pdb|3QQH|A Chain A, Cdk2 In Complex With Inhibitor L2-2
pdb|3QQJ|A Chain A, Cdk2 In Complex With Inhibitor L2
pdb|3QQL|A Chain A, Cdk2 In Complex With Inhibitor L3
pdb|3QRT|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc2-55
pdb|3QRU|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-12
pdb|3QWJ|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-142
pdb|3QWK|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-150
pdb|3QX2|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-190
pdb|3QX4|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-78
pdb|3QXO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-84
pdb|3QZF|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-52
pdb|3QZG|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-76
pdb|3QZH|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-124
pdb|3QZI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-126
pdb|3R1Q|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-102
pdb|3R1S|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-127
pdb|3R1Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-134
pdb|3R28|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-140
pdb|3R6X|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-158
pdb|3R71|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-162
pdb|3R73|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-164
pdb|3R7E|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-67
pdb|3R7I|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-74
pdb|3R7U|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-75
pdb|3R7V|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-9
pdb|3R7Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-88
pdb|3R83|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-92
pdb|3R8L|A Chain A, Cdk2 In Complex With Inhibitor L3-4
pdb|3R8M|A Chain A, Cdk2 In Complex With Inhibitor L3-3
pdb|3R8P|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-6
pdb|3RAI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-160
pdb|3RM6|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-80
pdb|3RM7|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-91
pdb|3ROY|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-154
pdb|3RPO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-156
pdb|4EZ3|A Chain A, Cdk2 In Complex With Nsc 134199
pdb|4EZ7|A Chain A, Cdk2 In Complex With Staurosporine And 2 Molecules Of
8-Anilino-1- Naphthalene Sulfonic Acid
pdb|3QQK|A Chain A, Cdk2 In Complex With Inhibitor L4
pdb|3QTQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-137
pdb|3QTR|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-148
pdb|3QTS|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-12
pdb|3QTU|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-132
pdb|3QTW|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-13
pdb|3QTX|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-35
pdb|3QTZ|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-36
pdb|3QU0|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-38
pdb|3QXP|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
pdb|3R8U|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-132
pdb|3R8V|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-135
pdb|3R8Z|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-136
pdb|3R9D|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-135
pdb|3R9H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-142
pdb|3R9N|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-21
pdb|3R9O|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-143
pdb|3RAH|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-22
pdb|3RAK|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-32
pdb|3RAL|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-34
pdb|3RJC|A Chain A, Cdk2 In Complex With Inhibitor L4-12
pdb|3RK5|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-72
pdb|3RK7|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-71
pdb|3RK9|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-74
pdb|3RKB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-73
pdb|3RMF|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-33
pdb|3RNI|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-86
pdb|3RPR|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-49
pdb|3RPV|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-88
pdb|3RPY|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-40
pdb|3RZB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-23
pdb|3S00|A Chain A, Cdk2 In Complex With Inhibitor L4-14
pdb|3S0O|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-138
pdb|3S1H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-39
pdb|3SQQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-96
pdb|4GCJ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
Length = 306
Score = 33.5 bits (75), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 35/125 (28%), Positives = 54/125 (43%), Gaps = 10/125 (8%)
Query: 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLASLQ 234
NF I EG V+Y+A + T + RL+ ++GV I +++ L L
Sbjct: 11 NFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 67
Query: 235 HPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCAAQG 293
HPN+ KLL ++ L++E L H L + + + G P+ L QG
Sbjct: 68 HPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL--QG 122
Query: 294 LTFLH 298
L F H
Sbjct: 123 LAFCH 127
>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
Length = 302
Score = 33.5 bits (75), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 22/72 (30%), Positives = 34/72 (47%), Gaps = 4/72 (5%)
Query: 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTL 230
+ NF I EG V+Y+A + T + RL+ ++GV I +++ L
Sbjct: 3 GSMENFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLL 59
Query: 231 ASLQHPNLCKLL 242
L HPN+ KLL
Sbjct: 60 KELNHPNIVKLL 71
>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A
Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine
Length = 299
Score = 33.5 bits (75), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 35/125 (28%), Positives = 54/125 (43%), Gaps = 10/125 (8%)
Query: 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLASLQ 234
NF I EG V+Y+A + T + RL+ ++GV I +++ L L
Sbjct: 4 NFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 235 HPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCAAQG 293
HPN+ KLL ++ L++E L H L + + + G P+ L QG
Sbjct: 61 HPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL--QG 115
Query: 294 LTFLH 298
L F H
Sbjct: 116 LAFCH 120
>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082
pdb|2HZ0|B Chain B, Abl Kinase Domain In Complex With Nvp-Aeg082
Length = 270
Score = 33.5 bits (75), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 35 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81
>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2
Complexed With A Nucleoside Inhibitor
Length = 298
Score = 33.5 bits (75), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 35/125 (28%), Positives = 54/125 (43%), Gaps = 10/125 (8%)
Query: 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLASLQ 234
NF I EG V+Y+A + T + RL+ ++GV I +++ L L
Sbjct: 3 NFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 59
Query: 235 HPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCAAQG 293
HPN+ KLL ++ L++E L H L + + + G P+ L QG
Sbjct: 60 HPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL--QG 114
Query: 294 LTFLH 298
L F H
Sbjct: 115 LAFCH 119
>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 298
Score = 33.5 bits (75), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 35/125 (28%), Positives = 54/125 (43%), Gaps = 10/125 (8%)
Query: 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLASLQ 234
NF I EG V+Y+A + T + RL+ ++GV I +++ L L
Sbjct: 5 NFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 235 HPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCAAQG 293
HPN+ KLL ++ L++E L H L + + + G P+ L QG
Sbjct: 62 HPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL--QG 116
Query: 294 LTFLH 298
L F H
Sbjct: 117 LAFCH 121
>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|C Chain C, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 296
Score = 33.5 bits (75), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 35/125 (28%), Positives = 54/125 (43%), Gaps = 10/125 (8%)
Query: 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLASLQ 234
NF I EG V+Y+A + T + RL+ ++GV I +++ L L
Sbjct: 3 NFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 59
Query: 235 HPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCAAQG 293
HPN+ KLL ++ L++E L H L + + + G P+ L QG
Sbjct: 60 HPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL--QG 114
Query: 294 LTFLH 298
L F H
Sbjct: 115 LAFCH 119
>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E
pdb|4EOR|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
Length = 298
Score = 33.5 bits (75), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 35/125 (28%), Positives = 54/125 (43%), Gaps = 10/125 (8%)
Query: 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLASLQ 234
NF I EG V+Y+A + T + RL+ ++GV I +++ L L
Sbjct: 4 NFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 235 HPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCAAQG 293
HPN+ KLL ++ L++E L H L + + + G P+ L QG
Sbjct: 61 HPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL--QG 115
Query: 294 LTFLH 298
L F H
Sbjct: 116 LAFCH 120
>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 302
Score = 33.5 bits (75), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 22/72 (30%), Positives = 34/72 (47%), Gaps = 4/72 (5%)
Query: 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTL 230
+ NF I EG V+Y+A + T + RL+ ++GV I +++ L
Sbjct: 3 GSMENFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLL 59
Query: 231 ASLQHPNLCKLL 242
L HPN+ KLL
Sbjct: 60 KELNHPNIVKLL 71
>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide,
Compound (S)-8b
pdb|3IG7|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efp With Cdk-2
pdb|3IGG|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efq With Cdk-2
pdb|1B38|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1B39|A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr 160
pdb|1E1V|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu2058
pdb|1E1X|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu6027
pdb|1H00|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H07|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H08|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|2R3R|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|4ACM|A Chain A, Cdk2 In Complex With
3-Amino-6-(4-{[2-(Dimethylamino)ethyl]
Sulfamoyl}-Phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
pdb|3SW4|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|3SW7|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|1OIQ|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
pdb|1V1K|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1URW|A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine
pdb|2VV9|A Chain A, Cdk2 In Complex With An Imidazole Piperazine
pdb|2W06|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5c
pdb|2R3G|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3H|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3F|A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 With
Inhibitor
Length = 299
Score = 33.5 bits (75), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 35/125 (28%), Positives = 54/125 (43%), Gaps = 10/125 (8%)
Query: 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLASLQ 234
NF I EG V+Y+A + T + RL+ ++GV I +++ L L
Sbjct: 4 NFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 235 HPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCAAQG 293
HPN+ KLL ++ L++E L H L + + + G P+ L QG
Sbjct: 61 HPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL--QG 115
Query: 294 LTFLH 298
L F H
Sbjct: 116 LAFCH 120
>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|C Chain C, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1GY3|A Chain A, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|C Chain C, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1P5E|A Chain A, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|C Chain C, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|2CCH|A Chain A, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|C Chain C, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCI|A Chain A, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|C Chain C, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2G9X|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|3DDP|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDQ|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DOG|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 299
Score = 33.5 bits (75), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 35/125 (28%), Positives = 54/125 (43%), Gaps = 10/125 (8%)
Query: 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLASLQ 234
NF I EG V+Y+A + T + RL+ ++GV I +++ L L
Sbjct: 4 NFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 235 HPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCAAQG 293
HPN+ KLL ++ L++E L H L + + + G P+ L QG
Sbjct: 61 HPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL--QG 115
Query: 294 LTFLH 298
L F H
Sbjct: 116 LAFCH 120
>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1CKP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Purvalanol B
pdb|1BUH|A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With
Cell Cycle-Regulatory Protein Ckshs1
pdb|1DM2|A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The
Inhibitor Hymenialdisine
pdb|1DI8|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
pdb|1F5Q|A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1FVT|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With An Oxindole Inhibitor
pdb|1FVV|A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1JSV|A Chain A, The Structure Of Cyclin-dependent Kinase 2 (cdk2) In
Complex With 4-[(6-amino-4-pyrimidinyl)
Amino]benzenesulfonamide
pdb|1G5S|A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2
(Cdk2) In Complex With The Inhibitor H717
pdb|1JVP|P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In
Complex With Pkf049-365
pdb|1GIH|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1KE5|A Chain A, Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h-
Indol-3-ylidene)methyl]amino}benzenesulfonamide
pdb|1KE6|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
N-Methyl-{4-
[2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8-
Ylidene)hydrazino]phenyl}methanesulfonamide
pdb|1KE7|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2-
Dioxido-1,
3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5-
(1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One
pdb|1KE8|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
4-{[(2-Oxo-
1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3-
Thiazol-2-Yl)benzenesulfonamide
pdb|1KE9|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4-
({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-
2- Oxo-2,3-Dihydro-1h-Indole
pdb|1H0V|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor
2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine
pdb|1H0W|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine
pdb|1P2A|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Trisubstituted Naphthostyril Inhibitor
pdb|1OKV|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|A Chain A, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|C Chain C, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|A Chain A, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|C Chain C, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1PW2|A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2
pdb|1PXI|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-
Ylamine
pdb|1PXJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
pdb|1PXK|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-
N'-hydroxyiminoformamide
pdb|1PXL|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-
(4-trifluoromethyl-phenyl)-amine
pdb|1R78|A Chain A, Cdk2 Complex With A 4-alkynyl Oxindole Inhibitor
pdb|1PXM|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-
Ylamino]-Phenol
pdb|1PXN|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-
Pyrimidin-2-Ylamino]-Phenol
pdb|1PXO|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-
Yl]-(3-Nitro-Phenyl)-Amine
pdb|1PXP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-
N',N'-Dimethyl-Benzene-1,4-Diamine
pdb|1VYZ|A Chain A, Structure Of Cdk2 Complexed With Pnu-181227
pdb|1PYE|A Chain A, Crystal Structure Of Cdk2 With Inhibitor
pdb|1URC|A Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|C Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1W0X|C Chain C, Crystals Structure Of Human Cdk2 In Complex With The
Inhibitor Olomoucine.
pdb|1WCC|A Chain A, Screening For Fragment Binding By X-Ray Crystallography
pdb|1Y8Y|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|1Y91|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|2BHE|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 5-Bromo-Indirubine
pdb|2BHH|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine
pdb|2B52|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Dph-
042562
pdb|2B53|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din-
234325
pdb|2B54|A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din-
232305
pdb|2B55|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Indenopyraxole Din-101312
pdb|2BTR|A Chain A, Structure Of Cdk2 Complexed With Pnu-198873
pdb|2BTS|A Chain A, Structure Of Cdk2 Complexed With Pnu-230032
pdb|2C68|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C69|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6I|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6K|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6L|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6M|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6O|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2EXM|A Chain A, Human Cdk2 In Complex With Isopentenyladenine
pdb|1YKR|A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine
Inhibitor
pdb|2A0C|X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9-
Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor
pdb|2C5N|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5Y|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2A4L|A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With
Roscovitine
pdb|2FVD|A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine
Inhibitor
pdb|2I40|A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2CLX|A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar
Study, Crystal Structure In Complex With Cdk2,
Selectivity, And Cellular Effects
pdb|2DUV|A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones
pdb|2UUE|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UZN|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZO|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2V0D|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|1AQ1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Staurosporine
pdb|1HCK|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1HCL|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|2J9M|A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic
Aminopyrimidine
pdb|2V22|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2VTA|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTH|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design
pdb|2VTI|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTJ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTL|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTM|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTN|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTO|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTP|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTQ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTR|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTS|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTT|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VU3|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2R64|A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With Cdk2
pdb|2W05|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5b
pdb|3EID|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|A Chain A, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|C Chain C, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2W1H|A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea
(At9283), A Multi-Targeted Kinase Inhibitor With Potent
Aurora Kinase Activity
pdb|3F5X|A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3FZ1|A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound To
Human Cyclin-Dependent Kinase-2 (Cdk-2)
pdb|2WEV|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|3LFN|A Chain A, Crystal Structure Of Cdk2 With Sar57, An Aminoindazole
Type Inhibitor
pdb|3LFQ|A Chain A, Crystal Structure Of Cdk2 With Sar60, An Aminoindazole
Type Inhibitor
pdb|3LFS|A Chain A, Crystal Structure Of Cdk2 With Sar37, An Aminoindazole
Type Inhibitor
pdb|2XMY|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|2XNB|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|3LE6|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Pyrazolobenzodiazepine Inhibitor
pdb|3NS9|A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor Bs-194
pdb|3S2P|A Chain A, Crystal Structure Of Cdk2 With A 2-Aminopyrimidine
Compound
pdb|3UNJ|A Chain A, Cdk2 In Complex With Inhibitor Yl1-038-31
pdb|3UNK|A Chain A, Cdk2 In Complex With Inhibitor Yl5-083
pdb|3TI1|A Chain A, Cdk2 In Complex With Sunitinib
pdb|3TIY|A Chain A, Cdk2 In Complex With Nsc 35676
pdb|3TIZ|A Chain A, Cdk2 In Complex With Nsc 111848
Length = 298
Score = 33.5 bits (75), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 35/125 (28%), Positives = 54/125 (43%), Gaps = 10/125 (8%)
Query: 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLASLQ 234
NF I EG V+Y+A + T + RL+ ++GV I +++ L L
Sbjct: 3 NFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 59
Query: 235 HPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCAAQG 293
HPN+ KLL ++ L++E L H L + + + G P+ L QG
Sbjct: 60 HPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL--QG 114
Query: 294 LTFLH 298
L F H
Sbjct: 115 LAFCH 119
>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|C Chain C, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|A Chain A, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|C Chain C, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|A Chain A, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|C Chain C, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|A Chain A, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|C Chain C, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|A Chain A, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|C Chain C, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|A Chain A, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|C Chain C, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|A Chain A, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|C Chain C, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|A Chain A, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|C Chain C, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 309
Score = 33.5 bits (75), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 35/125 (28%), Positives = 54/125 (43%), Gaps = 10/125 (8%)
Query: 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLASLQ 234
NF I EG V+Y+A + T + RL+ ++GV I +++ L L
Sbjct: 8 NFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 235 HPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCAAQG 293
HPN+ KLL ++ L++E L H L + + + G P+ L QG
Sbjct: 65 HPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL--QG 119
Query: 294 LTFLH 298
L F H
Sbjct: 120 LAFCH 124
>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|C Chain C, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JSU|A Chain A, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FQ1|B Chain B, Crystal Structure Of Kinase Associated Phosphatase (Kap)
In Complex With Phospho-Cdk2
pdb|2C6T|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|C Chain C, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|A Chain A, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|C Chain C, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2UZB|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4II5|A Chain A, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|C Chain C, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 298
Score = 33.5 bits (75), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 35/125 (28%), Positives = 54/125 (43%), Gaps = 10/125 (8%)
Query: 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLASLQ 234
NF I EG V+Y+A + T + RL+ ++GV I +++ L L
Sbjct: 3 NFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 59
Query: 235 HPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCAAQG 293
HPN+ KLL ++ L++E L H L + + + G P+ L QG
Sbjct: 60 HPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL--QG 114
Query: 294 LTFLH 298
L F H
Sbjct: 115 LAFCH 119
>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBT|D Chain D, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBW|B Chain B, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BBW|A Chain A, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BCE|A Chain A, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|B Chain B, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|C Chain C, Crystal Structure Of The Erbb4 Kinase
Length = 328
Score = 33.5 bits (75), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 30/123 (24%), Positives = 57/123 (46%), Gaps = 12/123 (9%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSS--QGVKEFINDVNTLASLQHPNL 238
+ + G +Y+ + + T K + LN ++ + EF+++ +AS+ HP+L
Sbjct: 21 KVLGSGAFGTVYKGIWVPEGETVK-IPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 79
Query: 239 CKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSD--GPPIDWNTRVKIALCAAQGLTF 296
+LLG S L+ + + HG L ++ D G + N V+I A+G+ +
Sbjct: 80 VRLLGVCL---SPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI----AKGMMY 132
Query: 297 LHE 299
L E
Sbjct: 133 LEE 135
>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
Length = 301
Score = 33.5 bits (75), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 22/72 (30%), Positives = 34/72 (47%), Gaps = 4/72 (5%)
Query: 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTL 230
+ NF I EG V+Y+A + T + RL+ ++GV I +++ L
Sbjct: 3 GSMENFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLL 59
Query: 231 ASLQHPNLCKLL 242
L HPN+ KLL
Sbjct: 60 KELNHPNIVKLL 71
>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 289
Score = 33.5 bits (75), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 35/128 (27%), Positives = 55/128 (42%), Gaps = 10/128 (7%)
Query: 173 ACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLA 231
+ NF I EG V+Y+A + T + RL+ ++GV I +++ L
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 232 SLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS-DGPPIDWNTRVKIALCA 290
L HPN+ KLL ++ L++E L H L + + + G P+ L
Sbjct: 58 ELNHPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL- 113
Query: 291 AQGLTFLH 298
QGL F H
Sbjct: 114 -QGLAFCH 120
>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 33.5 bits (75), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 22/72 (30%), Positives = 34/72 (47%), Gaps = 4/72 (5%)
Query: 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTL 230
+ NF I EG V+Y+A + T + RL+ ++GV I +++ L
Sbjct: 1 GSMENFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLL 57
Query: 231 ASLQHPNLCKLL 242
L HPN+ KLL
Sbjct: 58 KELNHPNIVKLL 69
>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 33.5 bits (75), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 20/65 (30%), Positives = 31/65 (47%), Gaps = 6/65 (9%)
Query: 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSS----QGVKEFINDVNTLASLQHPNL 238
+ +G V+ R + DA + K V L P + + +FI +VN + SL H NL
Sbjct: 26 LGDGSFGVVRRGEW--DAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 239 CKLLG 243
+L G
Sbjct: 84 IRLYG 88
>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U46|B Chain B, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U4D|A Chain A, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U4D|B Chain B, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U54|B Chain B, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 33.5 bits (75), Expect = 0.17, Method: Compositional matrix adjust.
Identities = 20/65 (30%), Positives = 31/65 (47%), Gaps = 6/65 (9%)
Query: 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSS----QGVKEFINDVNTLASLQHPNL 238
+ +G V+ R + DA + K V L P + + +FI +VN + SL H NL
Sbjct: 26 LGDGSFGVVRRGEW--DAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 239 CKLLG 243
+L G
Sbjct: 84 IRLYG 88
>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 33.5 bits (75), Expect = 0.17, Method: Compositional matrix adjust.
Identities = 22/72 (30%), Positives = 34/72 (47%), Gaps = 4/72 (5%)
Query: 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTL 230
+ NF I EG V+Y+A + T + RL+ ++GV I +++ L
Sbjct: 2 GSMENFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLL 58
Query: 231 ASLQHPNLCKLL 242
L HPN+ KLL
Sbjct: 59 KELNHPNIVKLL 70
>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor
Cis-3-[8-amino-1-(4-
Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol
Length = 273
Score = 33.5 bits (75), Expect = 0.17, Method: Compositional matrix adjust.
Identities = 20/65 (30%), Positives = 31/65 (47%), Gaps = 6/65 (9%)
Query: 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSS----QGVKEFINDVNTLASLQHPNL 238
+ +G V+ R + DA + K V L P + + +FI +VN + SL H NL
Sbjct: 16 LGDGSFGVVRRGEW--DAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 239 CKLLG 243
+L G
Sbjct: 74 IRLYG 78
>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor
pdb|4EWH|A Chain A, Co-Crystal Structure Of Ack1 With Inhibitor
Length = 275
Score = 33.5 bits (75), Expect = 0.17, Method: Compositional matrix adjust.
Identities = 20/65 (30%), Positives = 31/65 (47%), Gaps = 6/65 (9%)
Query: 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSS----QGVKEFINDVNTLASLQHPNL 238
+ +G V+ R + DA + K V L P + + +FI +VN + SL H NL
Sbjct: 16 LGDGSFGVVRRGEW--DAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 239 CKLLG 243
+L G
Sbjct: 74 IRLYG 78
>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Mgatp)
pdb|3REP|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Mnatp)
Length = 271
Score = 33.5 bits (75), Expect = 0.17, Method: Compositional matrix adjust.
Identities = 24/88 (27%), Positives = 43/88 (48%), Gaps = 1/88 (1%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
S++ ++F + L HPN+ +LG + LI + +GSL +++ ++
Sbjct: 47 STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF 106
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPF 303
+D + VK AL A+G+ FLH P
Sbjct: 107 V-VDQSQAVKFALDMARGMAFLHTLEPL 133
>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
Length = 302
Score = 33.5 bits (75), Expect = 0.17, Method: Compositional matrix adjust.
Identities = 22/72 (30%), Positives = 34/72 (47%), Gaps = 4/72 (5%)
Query: 172 AACHNFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTL 230
+ NF I EG V+Y+A + T + RL+ ++GV I +++ L
Sbjct: 3 GSMENFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLL 59
Query: 231 ASLQHPNLCKLL 242
L HPN+ KLL
Sbjct: 60 KELNHPNIVKLL 71
>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXR|B Chain B, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXS|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complexed With Pp2
Length = 268
Score = 33.5 bits (75), Expect = 0.17, Method: Compositional matrix adjust.
Identities = 22/93 (23%), Positives = 43/93 (46%), Gaps = 4/93 (4%)
Query: 205 KFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGS 264
+++ V + S EF + T+ L HP L K G +++ ++ E + +G
Sbjct: 32 QYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYP--IYIVTEYISNGC 89
Query: 265 LDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFL 297
L L Y RS G ++ + +++ +G+ FL
Sbjct: 90 L--LNYLRSHGKGLEPSQLLEMCYDVCEGMAFL 120
>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1GIJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|2DS1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
Length = 298
Score = 33.5 bits (75), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 22/68 (32%), Positives = 33/68 (48%), Gaps = 4/68 (5%)
Query: 176 NFFSDRCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-KEFINDVNTLASLQ 234
NF I EG V+Y+A + T + RL+ ++GV I +++ L L
Sbjct: 3 NFQKVEKIGEGTYGVVYKAR---NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 59
Query: 235 HPNLCKLL 242
HPN+ KLL
Sbjct: 60 HPNIVKLL 67
>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95
pdb|3EQP|A Chain A, Crystal Structure Of Ack1 With Compound T95
pdb|3EQR|A Chain A, Crystal Structure Of Ack1 With Compound T74
pdb|3EQR|B Chain B, Crystal Structure Of Ack1 With Compound T74
Length = 276
Score = 33.1 bits (74), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 20/65 (30%), Positives = 31/65 (47%), Gaps = 6/65 (9%)
Query: 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSS----QGVKEFINDVNTLASLQHPNL 238
+ +G V+ R + DA + K V L P + + +FI +VN + SL H NL
Sbjct: 16 LGDGSFGVVRRGEW--DAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 239 CKLLG 243
+L G
Sbjct: 74 IRLYG 78
>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain
pdb|4HZR|B Chain B, Crystal Structure Of Ack1 Kinase Domain
Length = 277
Score = 33.1 bits (74), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 20/65 (30%), Positives = 31/65 (47%), Gaps = 6/65 (9%)
Query: 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSS----QGVKEFINDVNTLASLQHPNL 238
+ +G V+ R + DA + K V L P + + +FI +VN + SL H NL
Sbjct: 20 LGDGSFGVVRRGEW--DAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 239 CKLLG 243
+L G
Sbjct: 78 IRLYG 82
>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 495
Score = 33.1 bits (74), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 242 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 288
>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|B Chain B, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|C Chain C, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|D Chain D, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
Length = 341
Score = 33.1 bits (74), Expect = 0.19, Method: Compositional matrix adjust.
Identities = 20/65 (30%), Positives = 31/65 (47%), Gaps = 6/65 (9%)
Query: 183 ISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSS----QGVKEFINDVNTLASLQHPNL 238
+ +G V+ R + DA + K V L P + + +FI +VN + SL H NL
Sbjct: 20 LGDGSFGVVRRGEW--DAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 239 CKLLG 243
+L G
Sbjct: 78 IRLYG 82
>pdb|2FO0|A Chain A, Organization Of The Sh3-Sh2 Unit In Active And Inactive
Forms Of The C-Abl Tyrosine Kinase
Length = 495
Score = 33.1 bits (74), Expect = 0.21, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 239 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 285
>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPL|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 537
Score = 33.1 bits (74), Expect = 0.22, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARD 248
KK+ TV L + V+EF+ + + ++HPNL +LLG R+
Sbjct: 281 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 327
>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase
Domain From Human
Length = 314
Score = 32.7 bits (73), Expect = 0.25, Method: Compositional matrix adjust.
Identities = 21/74 (28%), Positives = 35/74 (47%), Gaps = 6/74 (8%)
Query: 232 SLQHPNLCKLLGFHARDGSDQRMLIYERLFH--GSLDRLIYGRSDGPPIDWNTRVKIALC 289
++H NL + + R + + L FH GSL + G I WN +A
Sbjct: 65 GMKHENLLQFIAAEKRGSNLEVELWLITAFHDKGSLTDYLKGNI----ITWNELCHVAET 120
Query: 290 AAQGLTFLHEEGPF 303
++GL++LHE+ P+
Sbjct: 121 MSRGLSYLHEDVPW 134
>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Su11274
pdb|4AOT|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4AOT|B Chain B, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4EQU|A Chain A, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
pdb|4EQU|B Chain B, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
Length = 302
Score = 32.3 bits (72), Expect = 0.31, Method: Compositional matrix adjust.
Identities = 13/40 (32%), Positives = 24/40 (60%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRML 255
S + ++++I ++ LA+ HP + KLLG + DG M+
Sbjct: 56 SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95
>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Novel Bosutinib Isoform 1, Previously Thought
To Be Bosutinib
Length = 293
Score = 32.3 bits (72), Expect = 0.33, Method: Compositional matrix adjust.
Identities = 13/40 (32%), Positives = 24/40 (60%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRML 255
S + ++++I ++ LA+ HP + KLLG + DG M+
Sbjct: 48 SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 87
>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
Gleevec
pdb|3HMI|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
5-Amino-3-{[4-
(Aminosulfonyl)phenyl]amino}-N-(2,
6-Difluorophenyl)-1h-1,2,4- Triazole-1-Carbothioamide
pdb|2XYN|A Chain A, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|B Chain B, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|C Chain C, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
Length = 292
Score = 32.3 bits (72), Expect = 0.34, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 24/42 (57%), Gaps = 2/42 (4%)
Query: 204 KKFEATVT--RLNPSSQGVKEFINDVNTLASLQHPNLCKLLG 243
KK+ TV L + V+EF+ + + ++HPNL +LLG
Sbjct: 54 KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 95
>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)
pdb|3CBL|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (v- Fes) In Complex With Staurosporine And A
Consensus Peptide
pdb|4E93|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)in Complex With Tae684
Length = 377
Score = 32.3 bits (72), Expect = 0.39, Method: Compositional matrix adjust.
Identities = 25/110 (22%), Positives = 50/110 (45%), Gaps = 9/110 (8%)
Query: 193 RASFGDDASTSKKFEATVTRLNPSSQGV-----KEFINDVNTLASLQHPNLCKLLGFHAR 247
R +FG+ S + + T+ + + + +F+ + L HPN+ +L+G +
Sbjct: 124 RGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ 183
Query: 248 DGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFL 297
Q + I L G D L + R++G + T +++ AA G+ +L
Sbjct: 184 ---KQPIYIVMELVQGG-DFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL 229
>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma
Viral Oncogene Homologue (V-Fes) In Complex With
Staurosporine And A Consensus Peptide
Length = 377
Score = 32.0 bits (71), Expect = 0.40, Method: Compositional matrix adjust.
Identities = 26/116 (22%), Positives = 52/116 (44%), Gaps = 9/116 (7%)
Query: 187 LSSVMYRASFGDDASTSKKFEATVTRLNPSSQGV-----KEFINDVNTLASLQHPNLCKL 241
L + R +FG+ S + + T+ + + + +F+ + L HPN+ +L
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 242 LGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFL 297
+G + Q + I L G D L + R++G + T +++ AA G+ +L
Sbjct: 178 IGVCTQ---KQPIYIVMELVQGG-DFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL 229
>pdb|3A4O|X Chain X, Lyn Kinase Domain
Length = 286
Score = 32.0 bits (71), Expect = 0.44, Method: Compositional matrix adjust.
Identities = 17/59 (28%), Positives = 29/59 (49%), Gaps = 2/59 (3%)
Query: 207 EATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSL 265
+ V L P + V+ F+ + N + +LQH L +L R+ + +I E + GSL
Sbjct: 39 KVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTRE--EPIYIITEYMAKGSL 95
>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain
pdb|2IVU|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Zd6474
pdb|2X2K|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2L|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|B Chain B, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
Length = 314
Score = 32.0 bits (71), Expect = 0.46, Method: Compositional matrix adjust.
Identities = 17/52 (32%), Positives = 30/52 (57%), Gaps = 2/52 (3%)
Query: 214 NPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSL 265
N S +++ +++ N L + HP++ KL G ++DG +LI E +GSL
Sbjct: 64 NASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP--LLLIVEYAKYGSL 113
>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Pp1
Length = 314
Score = 32.0 bits (71), Expect = 0.46, Method: Compositional matrix adjust.
Identities = 17/52 (32%), Positives = 30/52 (57%), Gaps = 2/52 (3%)
Query: 214 NPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSL 265
N S +++ +++ N L + HP++ KL G ++DG +LI E +GSL
Sbjct: 64 NASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP--LLLIVEYAKYGSL 113
>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
pdb|2IVS|B Chain B, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
Length = 314
Score = 32.0 bits (71), Expect = 0.46, Method: Compositional matrix adjust.
Identities = 17/52 (32%), Positives = 30/52 (57%), Gaps = 2/52 (3%)
Query: 214 NPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSL 265
N S +++ +++ N L + HP++ KL G ++DG +LI E +GSL
Sbjct: 64 NASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP--LLLIVEYAKYGSL 113
>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1I|B Chain B, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 326
Score = 31.2 bits (69), Expect = 0.73, Method: Compositional matrix adjust.
Identities = 20/59 (33%), Positives = 30/59 (50%), Gaps = 1/59 (1%)
Query: 208 ATVTRLNPSSQ-GVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSL 265
V +L S++ +++F ++ L SLQH N+ K G G LI E L +GSL
Sbjct: 73 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 131
>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
pdb|4AQC|B Chain B, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
Length = 301
Score = 31.2 bits (69), Expect = 0.75, Method: Compositional matrix adjust.
Identities = 20/59 (33%), Positives = 30/59 (50%), Gaps = 1/59 (1%)
Query: 208 ATVTRLNPSSQ-GVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSL 265
V +L S++ +++F ++ L SLQH N+ K G G LI E L +GSL
Sbjct: 48 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 106
>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|2B7A|B Chain B, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|3FUP|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3FUP|B Chain B, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 293
Score = 31.2 bits (69), Expect = 0.76, Method: Compositional matrix adjust.
Identities = 20/59 (33%), Positives = 30/59 (50%), Gaps = 1/59 (1%)
Query: 208 ATVTRLNPSSQ-GVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSL 265
V +L S++ +++F ++ L SLQH N+ K G G LI E L +GSL
Sbjct: 40 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 98
>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
Length = 298
Score = 31.2 bits (69), Expect = 0.77, Method: Compositional matrix adjust.
Identities = 20/59 (33%), Positives = 30/59 (50%), Gaps = 1/59 (1%)
Query: 208 ATVTRLNPSSQ-GVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSL 265
V +L S++ +++F ++ L SLQH N+ K G G LI E L +GSL
Sbjct: 43 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 101
>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain
pdb|2XA4|B Chain B, Inhibitors Of Jak2 Kinase Domain
Length = 298
Score = 31.2 bits (69), Expect = 0.77, Method: Compositional matrix adjust.
Identities = 20/59 (33%), Positives = 30/59 (50%), Gaps = 1/59 (1%)
Query: 208 ATVTRLNPSSQ-GVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSL 265
V +L S++ +++F ++ L SLQH N+ K G G LI E L +GSL
Sbjct: 45 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 103
>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A
1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor
Length = 303
Score = 31.2 bits (69), Expect = 0.78, Method: Compositional matrix adjust.
Identities = 20/59 (33%), Positives = 30/59 (50%), Gaps = 1/59 (1%)
Query: 208 ATVTRLNPSSQ-GVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSL 265
V +L S++ +++F ++ L SLQH N+ K G G LI E L +GSL
Sbjct: 46 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 104
>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
pdb|4HGE|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
Length = 300
Score = 31.2 bits (69), Expect = 0.80, Method: Compositional matrix adjust.
Identities = 20/59 (33%), Positives = 30/59 (50%), Gaps = 1/59 (1%)
Query: 208 ATVTRLNPSSQ-GVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSL 265
V +L S++ +++F ++ L SLQH N+ K G G LI E L +GSL
Sbjct: 47 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 105
>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|D Chain D, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|E Chain E, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4F08|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F08|B Chain B, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F09|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
Length = 302
Score = 31.2 bits (69), Expect = 0.81, Method: Compositional matrix adjust.
Identities = 20/59 (33%), Positives = 30/59 (50%), Gaps = 1/59 (1%)
Query: 208 ATVTRLNPSSQ-GVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSL 265
V +L S++ +++F ++ L SLQH N+ K G G LI E L +GSL
Sbjct: 49 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 107
>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E63|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E64|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
Length = 293
Score = 31.2 bits (69), Expect = 0.82, Method: Compositional matrix adjust.
Identities = 20/59 (33%), Positives = 30/59 (50%), Gaps = 1/59 (1%)
Query: 208 ATVTRLNPSSQ-GVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSL 265
V +L S++ +++F ++ L SLQH N+ K G G LI E L +GSL
Sbjct: 41 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 99
>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii
Inhibtor Nvp-Bbt594
Length = 295
Score = 31.2 bits (69), Expect = 0.83, Method: Compositional matrix adjust.
Identities = 20/59 (33%), Positives = 30/59 (50%), Gaps = 1/59 (1%)
Query: 208 ATVTRLNPSSQ-GVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSL 265
V +L S++ +++F ++ L SLQH N+ K G G LI E L +GSL
Sbjct: 42 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 100
>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
pdb|3Q32|B Chain B, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
Length = 301
Score = 31.2 bits (69), Expect = 0.83, Method: Compositional matrix adjust.
Identities = 20/59 (33%), Positives = 30/59 (50%), Gaps = 1/59 (1%)
Query: 208 ATVTRLNPSSQ-GVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSL 265
V +L S++ +++F ++ L SLQH N+ K G G LI E L +GSL
Sbjct: 42 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 100
>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJC|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJD|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 19
pdb|3TJD|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 19
Length = 298
Score = 31.2 bits (69), Expect = 0.85, Method: Compositional matrix adjust.
Identities = 20/59 (33%), Positives = 30/59 (50%), Gaps = 1/59 (1%)
Query: 208 ATVTRLNPSSQ-GVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSL 265
V +L S++ +++F ++ L SLQH N+ K G G LI E L +GSL
Sbjct: 45 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 103
>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3LPB|B Chain B, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3KRR|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
Quinoxaline Atp Site Inhibitor
Length = 295
Score = 31.2 bits (69), Expect = 0.85, Method: Compositional matrix adjust.
Identities = 20/59 (33%), Positives = 30/59 (50%), Gaps = 1/59 (1%)
Query: 208 ATVTRLNPSSQ-GVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSL 265
V +L S++ +++F ++ L SLQH N+ K G G LI E L +GSL
Sbjct: 42 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 100
>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors
Length = 311
Score = 31.2 bits (69), Expect = 0.88, Method: Compositional matrix adjust.
Identities = 20/59 (33%), Positives = 30/59 (50%), Gaps = 1/59 (1%)
Query: 208 ATVTRLNPSSQ-GVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSL 265
V +L S++ +++F ++ L SLQH N+ K G G LI E L +GSL
Sbjct: 60 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 118
>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Apo)
Length = 271
Score = 30.8 bits (68), Expect = 0.92, Method: Compositional matrix adjust.
Identities = 24/88 (27%), Positives = 41/88 (46%), Gaps = 1/88 (1%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRSDG 275
S++ ++F + L HPN+ +LG + LI +GSL +++ ++
Sbjct: 47 STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWXPYGSLYNVLHEGTNF 106
Query: 276 PPIDWNTRVKIALCAAQGLTFLHEEGPF 303
+D + VK AL A+G FLH P
Sbjct: 107 V-VDQSQAVKFALDXARGXAFLHTLEPL 133
>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3KCK|A Chain A, A Novel Chemotype Of Kinase Inhibitors
Length = 313
Score = 30.8 bits (68), Expect = 0.93, Method: Compositional matrix adjust.
Identities = 20/59 (33%), Positives = 30/59 (50%), Gaps = 1/59 (1%)
Query: 208 ATVTRLNPSSQ-GVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSL 265
V +L S++ +++F ++ L SLQH N+ K G G LI E L +GSL
Sbjct: 60 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 118
>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6D|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6Q|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
pdb|4E6Q|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
Length = 298
Score = 30.8 bits (68), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 20/59 (33%), Positives = 30/59 (50%), Gaps = 1/59 (1%)
Query: 208 ATVTRLNPSSQ-GVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSL 265
V +L S++ +++F ++ L SLQH N+ K G G LI E L +GSL
Sbjct: 45 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSL 103
>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form
pdb|2ZV8|A Chain A, Lyn Tyrosine Kinase Domain-Amp-Pnp Complex
pdb|2ZV9|A Chain A, Lyn Tyrosine Kinase Domain-Pp2 Complex
pdb|2ZVA|A Chain A, Lyn Tyrosine Kinase Domain-dasatinib Complex
Length = 279
Score = 30.0 bits (66), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 16/59 (27%), Positives = 29/59 (49%), Gaps = 2/59 (3%)
Query: 207 EATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSL 265
+ V L P + V+ F+ + N + +LQH L +L ++ + +I E + GSL
Sbjct: 38 KVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE--EPIYIITEFMAKGSL 94
>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGW|B Chain B, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGY|A Chain A, Crystal Structure Of Itk Inhibitor Complex
pdb|3QGY|B Chain B, Crystal Structure Of Itk Inhibitor Complex
Length = 286
Score = 30.0 bits (66), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 22/96 (22%), Positives = 38/96 (39%), Gaps = 4/96 (4%)
Query: 204 KKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHG 263
K + + + S +FI + + L HP L +L G L++E + HG
Sbjct: 50 NKDKVAIKTIKEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLEQAP--ICLVFEFMEHG 107
Query: 264 SLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHE 299
L Y R+ T + + L +G+ +L E
Sbjct: 108 CLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEE 141
>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SM2|B Chain B, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|A Chain A, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|B Chain B, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNX|A Chain A, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
pdb|1SNX|B Chain B, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
Length = 264
Score = 29.6 bits (65), Expect = 2.5, Method: Compositional matrix adjust.
Identities = 21/96 (21%), Positives = 39/96 (40%), Gaps = 4/96 (4%)
Query: 204 KKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHG 263
K + + + + ++FI + + L HP L +L G L++E + HG
Sbjct: 28 NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP--ICLVFEFMEHG 85
Query: 264 SLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHE 299
L Y R+ T + + L +G+ +L E
Sbjct: 86 CLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEE 119
>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5J|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5L|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|C Chain C, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|D Chain D, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V8T|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8T|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8W|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
pdb|3V8W|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
Length = 266
Score = 29.6 bits (65), Expect = 2.5, Method: Compositional matrix adjust.
Identities = 21/96 (21%), Positives = 39/96 (40%), Gaps = 4/96 (4%)
Query: 204 KKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHG 263
K + + + + ++FI + + L HP L +L G L++E + HG
Sbjct: 30 NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP--ICLVFEFMEHG 87
Query: 264 SLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHE 299
L Y R+ T + + L +G+ +L E
Sbjct: 88 CLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEE 121
>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MIY|B Chain B, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MJ1|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Ro5191614
pdb|3MJ2|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Bms-509744
Length = 266
Score = 29.3 bits (64), Expect = 2.8, Method: Compositional matrix adjust.
Identities = 21/96 (21%), Positives = 39/96 (40%), Gaps = 4/96 (4%)
Query: 204 KKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHG 263
K + + + + ++FI + + L HP L +L G L++E + HG
Sbjct: 30 NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP--ICLVFEFMEHG 87
Query: 264 SLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHE 299
L Y R+ T + + L +G+ +L E
Sbjct: 88 CLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEE 121
>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52
pdb|4HCU|A Chain A, Crystal Structure Of Itk In Complext With Compound 40
pdb|4HCV|A Chain A, Crystal Structure Of Itk In Complex With Compound 53
Length = 269
Score = 29.3 bits (64), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 21/96 (21%), Positives = 39/96 (40%), Gaps = 4/96 (4%)
Query: 204 KKFEATVTRLNPSSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHG 263
K + + + + ++FI + + L HP L +L G L++E + HG
Sbjct: 33 NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP--ICLVFEFMEHG 90
Query: 264 SLDRLIYGRSDGPPIDWNTRVKIALCAAQGLTFLHE 299
L Y R+ T + + L +G+ +L E
Sbjct: 91 CLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEE 124
>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The
Murine Receptor Tyrosine Kinase Tyro3 (Sky)
Length = 323
Score = 29.3 bits (64), Expect = 3.4, Method: Compositional matrix adjust.
Identities = 23/89 (25%), Positives = 41/89 (46%), Gaps = 7/89 (7%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGFHARDGSDQR----MLIYERLFHGSLDR-LIY 270
+S ++EF+ + + HP++ KL+G R + R M+I + HG L L+
Sbjct: 65 ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLA 124
Query: 271 GRSDGPPID--WNTRVKIALCAAQGLTFL 297
R P + T V+ + A G+ +L
Sbjct: 125 SRIGENPFNLPLQTLVRFMVDIACGMEYL 153
>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2
pdb|3ZZW|B Chain B, Crystal Structure Of The Kinase Domain Of Ror2
Length = 289
Score = 28.9 bits (63), Expect = 3.4, Method: Compositional matrix adjust.
Identities = 18/53 (33%), Positives = 26/53 (49%), Gaps = 2/53 (3%)
Query: 221 KEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS 273
+EF ++ A LQHPN+ LLG +D +I+ HG L + RS
Sbjct: 57 EEFRHEAMLRARLQHPNVVCLLGVVTKD--QPLSMIFSYCSHGDLHEFLVMRS 107
>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain
pdb|4GT4|B Chain B, Structure Of Unliganded, Inactive Ror2 Kinase Domain
Length = 308
Score = 28.9 bits (63), Expect = 3.5, Method: Compositional matrix adjust.
Identities = 18/53 (33%), Positives = 26/53 (49%), Gaps = 2/53 (3%)
Query: 221 KEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLIYGRS 273
+EF ++ A LQHPN+ LLG +D +I+ HG L + RS
Sbjct: 74 EEFRHEAMLRARLQHPNVVCLLGVVTKD--QPLSMIFSYCSHGDLHEFLVMRS 124
>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (
Diphosphorylated Form) Bound To 5- Amino-3-((4-(
Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide
Length = 325
Score = 28.9 bits (63), Expect = 4.1, Method: Compositional matrix adjust.
Identities = 10/27 (37%), Positives = 20/27 (74%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLL 242
S + +++++ +++ LAS HPN+ KLL
Sbjct: 74 SEEELEDYMVEIDILASCDHPNIVKLL 100
>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded
Form)
Length = 325
Score = 28.9 bits (63), Expect = 4.1, Method: Compositional matrix adjust.
Identities = 10/27 (37%), Positives = 20/27 (74%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLL 242
S + +++++ +++ LAS HPN+ KLL
Sbjct: 74 SEEELEDYMVEIDILASCDHPNIVKLL 100
>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5-
Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide
Length = 325
Score = 28.9 bits (63), Expect = 4.1, Method: Compositional matrix adjust.
Identities = 10/27 (37%), Positives = 20/27 (74%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLL 242
S + +++++ +++ LAS HPN+ KLL
Sbjct: 74 SEEELEDYMVEIDILASCDHPNIVKLL 100
>pdb|2UV2|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To
4-(4-(
5-Cyclopropyl-1h-Pyrazol-3-Ylamino)-Quinazolin-2-
Ylamino)- Phenyl)-Acetonitrile
Length = 287
Score = 28.9 bits (63), Expect = 4.3, Method: Compositional matrix adjust.
Identities = 10/27 (37%), Positives = 20/27 (74%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLL 242
S + +++++ +++ LAS HPN+ KLL
Sbjct: 47 SEEELEDYMVEIDILASCDHPNIVKLL 73
>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And
Kinase Domains
Length = 361
Score = 28.9 bits (63), Expect = 4.3, Method: Compositional matrix adjust.
Identities = 10/29 (34%), Positives = 20/29 (68%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGF 244
S + KE +++ +AS+ +P++C+LLG
Sbjct: 91 SPKANKEILDEAYVMASVDNPHVCRLLGI 119
>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole
Inhibitor
Length = 291
Score = 28.9 bits (63), Expect = 4.4, Method: Compositional matrix adjust.
Identities = 13/49 (26%), Positives = 28/49 (57%), Gaps = 2/49 (4%)
Query: 221 KEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLI 269
+EF+++ + + +HPN+ +L G S M++ E + +G+LD +
Sbjct: 60 REFLSEASIMGQFEHPNIIRLEGVVT--NSMPVMILTEFMENGALDSFL 106
>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase
Domain With Erlotinib
Length = 337
Score = 28.9 bits (63), Expect = 4.4, Method: Compositional matrix adjust.
Identities = 10/29 (34%), Positives = 20/29 (68%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGF 244
S + KE +++ +AS+ +P++C+LLG
Sbjct: 67 SPKANKEILDEAYVMASVDNPHVCRLLGI 95
>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Aee788
pdb|2ITU|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Afn941
pdb|2ITV|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Amp-pnp
pdb|2ITZ|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Iressa
Length = 327
Score = 28.9 bits (63), Expect = 4.4, Method: Compositional matrix adjust.
Identities = 10/29 (34%), Positives = 20/29 (68%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGF 244
S + KE +++ +AS+ +P++C+LLG
Sbjct: 57 SPKANKEILDEAYVMASVDNPHVCRLLGI 85
>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic
Mutant L858r Egfr Kinase Domain
Length = 329
Score = 28.5 bits (62), Expect = 4.5, Method: Compositional matrix adjust.
Identities = 10/29 (34%), Positives = 20/29 (68%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGF 244
S + KE +++ +AS+ +P++C+LLG
Sbjct: 59 SPKANKEILDEAYVMASVDNPHVCRLLGI 87
>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The
Gefitinib/erlotinib Resistant Egfr Kinase Domain
L858r+t790m
pdb|4I22|A Chain A, Structure Of The Monomeric (v948r)gefitinib/erlotinib
Resistant Double Mutant (l858r+t790m) Egfr Kinase Domain
Co-crystallized With Gefitinib
Length = 329
Score = 28.5 bits (62), Expect = 4.5, Method: Compositional matrix adjust.
Identities = 10/29 (34%), Positives = 20/29 (68%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGF 244
S + KE +++ +AS+ +P++C+LLG
Sbjct: 59 SPKANKEILDEAYVMASVDNPHVCRLLGI 87
>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
pdb|4I21|B Chain B, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
Length = 329
Score = 28.5 bits (62), Expect = 4.5, Method: Compositional matrix adjust.
Identities = 10/29 (34%), Positives = 20/29 (68%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGF 244
S + KE +++ +AS+ +P++C+LLG
Sbjct: 59 SPKANKEILDEAYVMASVDNPHVCRLLGI 87
>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In
Complex With Amppnp
Length = 334
Score = 28.5 bits (62), Expect = 4.5, Method: Compositional matrix adjust.
Identities = 10/29 (34%), Positives = 20/29 (68%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGF 244
S + KE +++ +AS+ +P++C+LLG
Sbjct: 64 SPKANKEILDEAYVMASVDNPHVCRLLGI 92
>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
pdb|3IKA|B Chain B, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
Length = 331
Score = 28.5 bits (62), Expect = 4.5, Method: Compositional matrix adjust.
Identities = 10/29 (34%), Positives = 20/29 (68%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGF 244
S + KE +++ +AS+ +P++C+LLG
Sbjct: 61 SPKANKEILDEAYVMASVDNPHVCRLLGI 89
>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Amp-Pnp
pdb|2ITO|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Iressa
pdb|2ITP|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Aee788
pdb|2ITQ|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Afn941
Length = 327
Score = 28.5 bits (62), Expect = 4.5, Method: Compositional matrix adjust.
Identities = 10/29 (34%), Positives = 20/29 (68%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGF 244
S + KE +++ +AS+ +P++C+LLG
Sbjct: 57 SPKANKEILDEAYVMASVDNPHVCRLLGI 85
>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285
pdb|3W2P|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 2
pdb|3W2Q|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Hki-272
pdb|3W2R|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 4
Length = 331
Score = 28.5 bits (62), Expect = 4.6, Method: Compositional matrix adjust.
Identities = 10/29 (34%), Positives = 20/29 (68%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGF 244
S + KE +++ +AS+ +P++C+LLG
Sbjct: 61 SPKANKEILDEAYVMASVDNPHVCRLLGI 89
>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
pdb|4I24|B Chain B, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
Length = 329
Score = 28.5 bits (62), Expect = 4.6, Method: Compositional matrix adjust.
Identities = 10/29 (34%), Positives = 20/29 (68%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGF 244
S + KE +++ +AS+ +P++C+LLG
Sbjct: 59 SPKANKEILDEAYVMASVDNPHVCRLLGI 87
>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor
pdb|2RGP|A Chain A, Structure Of Egfr In Complex With Hydrazone, A Potent Dual
Inhibitor
Length = 315
Score = 28.5 bits (62), Expect = 4.6, Method: Compositional matrix adjust.
Identities = 10/29 (34%), Positives = 20/29 (68%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGF 244
S + KE +++ +AS+ +P++C+LLG
Sbjct: 51 SPKANKEILDEAYVMASVDNPHVCRLLGI 79
>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
pdb|2JIV|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
Length = 328
Score = 28.5 bits (62), Expect = 4.6, Method: Compositional matrix adjust.
Identities = 10/29 (34%), Positives = 20/29 (68%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGF 244
S + KE +++ +AS+ +P++C+LLG
Sbjct: 58 SPKANKEILDEAYVMASVDNPHVCRLLGI 86
>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 13-Jab
Length = 327
Score = 28.5 bits (62), Expect = 4.6, Method: Compositional matrix adjust.
Identities = 10/29 (34%), Positives = 20/29 (68%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGF 244
S + KE +++ +AS+ +P++C+LLG
Sbjct: 57 SPKANKEILDEAYVMASVDNPHVCRLLGI 85
>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|2GS7|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|C Chain C, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|D Chain D, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
Length = 330
Score = 28.5 bits (62), Expect = 4.6, Method: Compositional matrix adjust.
Identities = 10/29 (34%), Positives = 20/29 (68%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGF 244
S + KE +++ +AS+ +P++C+LLG
Sbjct: 60 SPKANKEILDEAYVMASVDNPHVCRLLGI 88
>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992
Length = 330
Score = 28.5 bits (62), Expect = 4.6, Method: Compositional matrix adjust.
Identities = 10/29 (34%), Positives = 20/29 (68%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGF 244
S + KE +++ +AS+ +P++C+LLG
Sbjct: 60 SPKANKEILDEAYVMASVDNPHVCRLLGI 88
>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN The Apo Form
pdb|3UG2|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Gefitinib
pdb|3VJN|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Amppnp
Length = 334
Score = 28.5 bits (62), Expect = 4.6, Method: Compositional matrix adjust.
Identities = 10/29 (34%), Positives = 20/29 (68%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGF 244
S + KE +++ +AS+ +P++C+LLG
Sbjct: 64 SPKANKEILDEAYVMASVDNPHVCRLLGI 92
>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s)
Length = 334
Score = 28.5 bits (62), Expect = 4.6, Method: Compositional matrix adjust.
Identities = 10/29 (34%), Positives = 20/29 (68%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGF 244
S + KE +++ +AS+ +P++C+LLG
Sbjct: 64 SPKANKEILDEAYVMASVDNPHVCRLLGI 92
>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In
Complex With Amppnp
Length = 334
Score = 28.5 bits (62), Expect = 4.7, Method: Compositional matrix adjust.
Identities = 10/29 (34%), Positives = 20/29 (68%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGF 244
S + KE +++ +AS+ +P++C+LLG
Sbjct: 64 SPKANKEILDEAYVMASVDNPHVCRLLGI 92
>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFD|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|C Chain C, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|D Chain D, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
Length = 324
Score = 28.5 bits (62), Expect = 4.7, Method: Compositional matrix adjust.
Identities = 10/29 (34%), Positives = 20/29 (68%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGF 244
S + KE +++ +AS+ +P++C+LLG
Sbjct: 54 SPKANKEILDEAYVMASVDNPHVCRLLGI 82
>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 34-Jab
pdb|2ITW|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Afn941
pdb|2ITX|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Amp- Pnp
pdb|2ITY|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Iressa
pdb|2J6M|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Aee788
pdb|3POZ|A Chain A, Egfr Kinase Domain Complexed With Tak-285
Length = 327
Score = 28.5 bits (62), Expect = 4.7, Method: Compositional matrix adjust.
Identities = 10/29 (34%), Positives = 20/29 (68%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGF 244
S + KE +++ +AS+ +P++C+LLG
Sbjct: 57 SPKANKEILDEAYVMASVDNPHVCRLLGI 85
>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain
pdb|2GS6|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain In
Complex With An Atp Analog-Peptide Conjugate
pdb|2RF9|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RF9|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|3W2S|A Chain A, Egfr Kinase Domain With Compound4
Length = 330
Score = 28.5 bits (62), Expect = 4.7, Method: Compositional matrix adjust.
Identities = 10/29 (34%), Positives = 20/29 (68%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGF 244
S + KE +++ +AS+ +P++C+LLG
Sbjct: 60 SPKANKEILDEAYVMASVDNPHVCRLLGI 88
>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
pdb|4G5P|B Chain B, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
Length = 330
Score = 28.5 bits (62), Expect = 4.7, Method: Compositional matrix adjust.
Identities = 10/29 (34%), Positives = 20/29 (68%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGF 244
S + KE +++ +AS+ +P++C+LLG
Sbjct: 60 SPKANKEILDEAYVMASVDNPHVCRLLGI 88
>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In
Complex With Dacomitinib (soaked)
Length = 329
Score = 28.5 bits (62), Expect = 4.8, Method: Compositional matrix adjust.
Identities = 10/29 (34%), Positives = 20/29 (68%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGF 244
S + KE +++ +AS+ +P++C+LLG
Sbjct: 59 SPKANKEILDEAYVMASVDNPHVCRLLGI 87
>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor-
Gw572016
Length = 352
Score = 28.5 bits (62), Expect = 4.8, Method: Compositional matrix adjust.
Identities = 10/29 (34%), Positives = 20/29 (68%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGF 244
S + KE +++ +AS+ +P++C+LLG
Sbjct: 82 SPKANKEILDEAYVMASVDNPHVCRLLGI 110
>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor
Receptor
pdb|1M17|A Chain A, Epidermal Growth Factor Receptor Tyrosine Kinase Domain
With 4-Anilinoquinazoline Inhibitor Erlotinib
Length = 333
Score = 28.5 bits (62), Expect = 4.8, Method: Compositional matrix adjust.
Identities = 10/29 (34%), Positives = 20/29 (68%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGF 244
S + KE +++ +AS+ +P++C+LLG
Sbjct: 63 SPKANKEILDEAYVMASVDNPHVCRLLGI 91
>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWV|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWW|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWX|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWY|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWZ|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX0|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX1|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2X9F|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2XVD|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|4BB4|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
Length = 302
Score = 28.5 bits (62), Expect = 4.8, Method: Compositional matrix adjust.
Identities = 13/49 (26%), Positives = 28/49 (57%), Gaps = 2/49 (4%)
Query: 221 KEFINDVNTLASLQHPNLCKLLGFHARDGSDQRMLIYERLFHGSLDRLI 269
+EF+++ + + +HPN+ +L G S M++ E + +G+LD +
Sbjct: 62 REFLSEASIMGQFEHPNIIRLEGVVT--NSMPVMILTEFMENGALDSFL 108
>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
pdb|2JIU|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
Length = 328
Score = 28.5 bits (62), Expect = 4.8, Method: Compositional matrix adjust.
Identities = 10/29 (34%), Positives = 20/29 (68%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGF 244
S + KE +++ +AS+ +P++C+LLG
Sbjct: 58 SPKANKEILDEAYVMASVDNPHVCRLLGI 86
>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation
pdb|2JIT|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation
Length = 327
Score = 28.5 bits (62), Expect = 4.8, Method: Compositional matrix adjust.
Identities = 10/29 (34%), Positives = 20/29 (68%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGF 244
S + KE +++ +AS+ +P++C+LLG
Sbjct: 57 SPKANKEILDEAYVMASVDNPHVCRLLGI 85
>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|B Chain B, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|C Chain C, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|D Chain D, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|E Chain E, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|F Chain F, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|G Chain G, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|H Chain H, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
Length = 327
Score = 28.5 bits (62), Expect = 4.9, Method: Compositional matrix adjust.
Identities = 10/29 (34%), Positives = 20/29 (68%)
Query: 216 SSQGVKEFINDVNTLASLQHPNLCKLLGF 244
S + KE +++ +AS+ +P++C+LLG
Sbjct: 57 SPKANKEILDEAYVMASVDNPHVCRLLGI 85
>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|D Chain D, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|F Chain F, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|H Chain H, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1IAS|A Chain A, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|B Chain B, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|C Chain C, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|D Chain D, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|E Chain E, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|3FAA|A Chain A, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|B Chain B, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|C Chain C, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|D Chain D, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|E Chain E, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3KCF|A Chain A, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|B Chain B, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|C Chain C, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|D Chain D, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|E Chain E, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|2X7O|A Chain A, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|B Chain B, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|C Chain C, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|D Chain D, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|E Chain E, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
Length = 342
Score = 27.7 bits (60), Expect = 7.8, Method: Compositional matrix adjust.
Identities = 24/73 (32%), Positives = 33/73 (45%), Gaps = 12/73 (16%)
Query: 233 LQHPNLCKLLGFHARDGSD-----QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIA 287
L+H N+ LGF A D D Q L+ + HGSL + + + +K+A
Sbjct: 93 LRHENI---LGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLA 145
Query: 288 LCAAQGLTFLHEE 300
L A GL LH E
Sbjct: 146 LSTASGLAHLHME 158
>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With
Inhibitor
Length = 326
Score = 27.7 bits (60), Expect = 8.2, Method: Compositional matrix adjust.
Identities = 24/73 (32%), Positives = 33/73 (45%), Gaps = 12/73 (16%)
Query: 233 LQHPNLCKLLGFHARDGSD-----QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIA 287
L+H N+ LGF A D D Q L+ + HGSL + + + +K+A
Sbjct: 80 LRHENI---LGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLA 132
Query: 288 LCAAQGLTFLHEE 300
L A GL LH E
Sbjct: 133 LSTASGLAHLHME 145
>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human
Tgf- Beta Type I Receptor
pdb|3GXL|A Chain A, Alk-5 Kinase Complex With Gw857175
pdb|3HMM|A Chain A, Structure Of Alk5 + Gw855857
Length = 303
Score = 27.7 bits (60), Expect = 8.3, Method: Compositional matrix adjust.
Identities = 24/73 (32%), Positives = 33/73 (45%), Gaps = 12/73 (16%)
Query: 233 LQHPNLCKLLGFHARDGSD-----QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIA 287
L+H N+ LGF A D D Q L+ + HGSL + + + +K+A
Sbjct: 54 LRHENI---LGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLA 106
Query: 288 LCAAQGLTFLHEE 300
L A GL LH E
Sbjct: 107 LSTASGLAHLHME 119
>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542
Length = 309
Score = 27.7 bits (60), Expect = 8.3, Method: Compositional matrix adjust.
Identities = 24/73 (32%), Positives = 33/73 (45%), Gaps = 12/73 (16%)
Query: 233 LQHPNLCKLLGFHARDGSD-----QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIA 287
L+H N+ LGF A D D Q L+ + HGSL + + + +K+A
Sbjct: 60 LRHENI---LGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLA 112
Query: 288 LCAAQGLTFLHEE 300
L A GL LH E
Sbjct: 113 LSTASGLAHLHME 125
>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp
Site Inhibitor
Length = 301
Score = 27.7 bits (60), Expect = 8.4, Method: Compositional matrix adjust.
Identities = 24/73 (32%), Positives = 33/73 (45%), Gaps = 12/73 (16%)
Query: 233 LQHPNLCKLLGFHARDGSD-----QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIA 287
L+H N+ LGF A D D Q L+ + HGSL + + + +K+A
Sbjct: 55 LRHENI---LGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLA 107
Query: 288 LCAAQGLTFLHEE 300
L A GL LH E
Sbjct: 108 LSTASGLAHLHME 120
>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3-
Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine
pdb|2WOU|A Chain A, Alk5 In Complex With
4-((4-((2,6-Dimethyl-3-Pyridyl)oxy)-2-
Pyridyl)amino)benzenesulfonamide
Length = 306
Score = 27.7 bits (60), Expect = 8.8, Method: Compositional matrix adjust.
Identities = 24/73 (32%), Positives = 33/73 (45%), Gaps = 12/73 (16%)
Query: 233 LQHPNLCKLLGFHARDGSD-----QRMLIYERLFHGSLDRLIYGRSDGPPIDWNTRVKIA 287
L+H N+ LGF A D D Q L+ + HGSL + + + +K+A
Sbjct: 57 LRHENI---LGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLA 109
Query: 288 LCAAQGLTFLHEE 300
L A GL LH E
Sbjct: 110 LSTASGLAHLHME 122
>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains.
pdb|2J0K|B Chain B, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains
Length = 656
Score = 27.7 bits (60), Expect = 8.9, Method: Compositional matrix adjust.
Identities = 18/64 (28%), Positives = 32/64 (50%), Gaps = 2/64 (3%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKE-FINDVNTLASLQHPNLC 239
RCI EG +++ + + + A T N +S V+E F+ + T+ HP++
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAV-AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 240 KLLG 243
KL+G
Sbjct: 455 KLIG 458
>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
pdb|2JKO|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 27.7 bits (60), Expect = 9.4, Method: Compositional matrix adjust.
Identities = 18/64 (28%), Positives = 32/64 (50%), Gaps = 2/64 (3%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKE-FINDVNTLASLQHPNLC 239
RCI EG +++ + + + A T N +S V+E F+ + T+ HP++
Sbjct: 16 RCIGEGQFGDVHQGIYMSPENPAMAV-AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 240 KLLG 243
KL+G
Sbjct: 75 KLIG 78
>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains
Length = 656
Score = 27.7 bits (60), Expect = 9.4, Method: Compositional matrix adjust.
Identities = 18/64 (28%), Positives = 32/64 (50%), Gaps = 2/64 (3%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKE-FINDVNTLASLQHPNLC 239
RCI EG +++ + + + A T N +S V+E F+ + T+ HP++
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAV-AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 240 KLLG 243
KL+G
Sbjct: 455 KLIG 458
>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 27.7 bits (60), Expect = 9.5, Method: Compositional matrix adjust.
Identities = 18/64 (28%), Positives = 32/64 (50%), Gaps = 2/64 (3%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKE-FINDVNTLASLQHPNLC 239
RCI EG +++ + + + A T N +S V+E F+ + T+ HP++
Sbjct: 16 RCIGEGQFGDVHQGIYMSPENPAMAV-AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 240 KLLG 243
KL+G
Sbjct: 75 KLIG 78
>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The
Kinase Domain Of Focal Adhesion Kinase With A
Phosphorylated Activation Loop
Length = 276
Score = 27.7 bits (60), Expect = 9.7, Method: Compositional matrix adjust.
Identities = 18/64 (28%), Positives = 32/64 (50%), Gaps = 2/64 (3%)
Query: 181 RCISEGLSSVMYRASFGDDASTSKKFEATVTRLNPSSQGVKE-FINDVNTLASLQHPNLC 239
RCI EG +++ + + + A T N +S V+E F+ + T+ HP++
Sbjct: 16 RCIGEGQFGDVHQGIYMSPENPAMAV-AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 240 KLLG 243
KL+G
Sbjct: 75 KLIG 78
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.318 0.132 0.389
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 7,301,219
Number of Sequences: 62578
Number of extensions: 246769
Number of successful extensions: 793
Number of sequences better than 100.0: 205
Number of HSP's better than 100.0 without gapping: 106
Number of HSP's successfully gapped in prelim test: 99
Number of HSP's that attempted gapping in prelim test: 673
Number of HSP's gapped (non-prelim): 205
length of query: 316
length of database: 14,973,337
effective HSP length: 99
effective length of query: 217
effective length of database: 8,778,115
effective search space: 1904850955
effective search space used: 1904850955
T: 11
A: 40
X1: 16 ( 7.3 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.7 bits)
S2: 51 (24.3 bits)